KR102015783B1 - Black ginseng fermented jelly and its manufacturing method - Google Patents
Black ginseng fermented jelly and its manufacturing method Download PDFInfo
- Publication number
- KR102015783B1 KR102015783B1 KR1020190015048A KR20190015048A KR102015783B1 KR 102015783 B1 KR102015783 B1 KR 102015783B1 KR 1020190015048 A KR1020190015048 A KR 1020190015048A KR 20190015048 A KR20190015048 A KR 20190015048A KR 102015783 B1 KR102015783 B1 KR 102015783B1
- Authority
- KR
- South Korea
- Prior art keywords
- black ginseng
- weight
- parts
- jelly
- fermentation
- Prior art date
Links
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 220
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 220
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 220
- 235000015110 jellies Nutrition 0.000 title claims abstract description 71
- 239000008274 jelly Substances 0.000 title claims abstract description 71
- 241000208340 Araliaceae Species 0.000 title claims abstract 23
- 238000004519 manufacturing process Methods 0.000 title claims description 42
- 239000000203 mixture Substances 0.000 claims abstract description 66
- 239000000463 material Substances 0.000 claims abstract description 30
- 238000002156 mixing Methods 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 20
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 17
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 17
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 17
- 238000003756 stirring Methods 0.000 claims abstract description 15
- 238000001816 cooling Methods 0.000 claims abstract description 12
- 238000011049 filling Methods 0.000 claims abstract description 12
- 230000001954 sterilising effect Effects 0.000 claims abstract description 12
- 239000012258 stirred mixture Substances 0.000 claims abstract description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 158
- 238000000855 fermentation Methods 0.000 claims description 135
- 230000004151 fermentation Effects 0.000 claims description 135
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 93
- 239000000843 powder Substances 0.000 claims description 90
- 239000004310 lactic acid Substances 0.000 claims description 79
- 235000014655 lactic acid Nutrition 0.000 claims description 79
- 239000012141 concentrate Substances 0.000 claims description 71
- 241000894006 Bacteria Species 0.000 claims description 69
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 60
- 239000000796 flavoring agent Substances 0.000 claims description 45
- 102000004190 Enzymes Human genes 0.000 claims description 43
- 108090000790 Enzymes Proteins 0.000 claims description 43
- 235000019634 flavors Nutrition 0.000 claims description 38
- 238000002360 preparation method Methods 0.000 claims description 32
- 235000002789 Panax ginseng Nutrition 0.000 claims description 31
- 244000228451 Stevia rebaudiana Species 0.000 claims description 31
- 235000015165 citric acid Nutrition 0.000 claims description 31
- 229960004106 citric acid Drugs 0.000 claims description 31
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 31
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 31
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 30
- 239000004376 Sucralose Substances 0.000 claims description 30
- 229930003268 Vitamin C Natural products 0.000 claims description 30
- 235000019408 sucralose Nutrition 0.000 claims description 30
- 239000011718 vitamin C Substances 0.000 claims description 30
- 235000019154 vitamin C Nutrition 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 239000001509 sodium citrate Substances 0.000 claims description 29
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 29
- 235000019263 trisodium citrate Nutrition 0.000 claims description 29
- 229940038773 trisodium citrate Drugs 0.000 claims description 29
- 239000008213 purified water Substances 0.000 claims description 24
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 23
- 229920002752 Konjac Polymers 0.000 claims description 23
- 239000000679 carrageenan Substances 0.000 claims description 23
- 235000010418 carrageenan Nutrition 0.000 claims description 23
- 229920001525 carrageenan Polymers 0.000 claims description 23
- 229940113118 carrageenan Drugs 0.000 claims description 23
- 239000000230 xanthan gum Substances 0.000 claims description 23
- 229920001285 xanthan gum Polymers 0.000 claims description 23
- 235000010493 xanthan gum Nutrition 0.000 claims description 23
- 229940082509 xanthan gum Drugs 0.000 claims description 23
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 23
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 22
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 22
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 22
- 239000000252 konjac Substances 0.000 claims description 22
- 235000010485 konjac Nutrition 0.000 claims description 22
- 235000013325 dietary fiber Nutrition 0.000 claims description 16
- 235000003599 food sweetener Nutrition 0.000 claims description 14
- 239000003765 sweetening agent Substances 0.000 claims description 14
- 238000004806 packaging method and process Methods 0.000 claims description 11
- 239000004386 Erythritol Substances 0.000 claims description 10
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 10
- 229940009714 erythritol Drugs 0.000 claims description 10
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 10
- 235000019414 erythritol Nutrition 0.000 claims description 10
- 235000013618 yogurt Nutrition 0.000 claims description 9
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 8
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 8
- 240000006432 Carica papaya Species 0.000 claims description 8
- 235000009467 Carica papaya Nutrition 0.000 claims description 8
- 244000298697 Actinidia deliciosa Species 0.000 claims description 7
- 235000013373 food additive Nutrition 0.000 claims description 7
- 239000002778 food additive Substances 0.000 claims description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 abstract description 15
- 241000186660 Lactobacillus Species 0.000 abstract description 13
- 239000007788 liquid Substances 0.000 abstract description 9
- 240000004371 Panax ginseng Species 0.000 description 197
- 229940088598 enzyme Drugs 0.000 description 42
- 230000000694 effects Effects 0.000 description 41
- 230000000052 comparative effect Effects 0.000 description 35
- 239000000243 solution Substances 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 25
- 235000000346 sugar Nutrition 0.000 description 21
- 229920002774 Maltodextrin Polymers 0.000 description 18
- 239000005913 Maltodextrin Substances 0.000 description 18
- 230000008859 change Effects 0.000 description 18
- 229940035034 maltodextrin Drugs 0.000 description 18
- 235000019658 bitter taste Nutrition 0.000 description 17
- 239000002253 acid Substances 0.000 description 16
- 240000008790 Musa x paradisiaca Species 0.000 description 14
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 14
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 13
- 210000000941 bile Anatomy 0.000 description 13
- 239000008101 lactose Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 235000009754 Vitis X bourquina Nutrition 0.000 description 12
- 235000012333 Vitis X labruscana Nutrition 0.000 description 12
- 240000006365 Vitis vinifera Species 0.000 description 12
- 235000014787 Vitis vinifera Nutrition 0.000 description 12
- 229930182494 ginsenoside Natural products 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- 229940089161 ginsenoside Drugs 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 230000004083 survival effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000007423 decrease Effects 0.000 description 9
- 238000011081 inoculation Methods 0.000 description 9
- 210000000822 natural killer cell Anatomy 0.000 description 9
- 235000000832 Ayote Nutrition 0.000 description 8
- 240000004244 Cucurbita moschata Species 0.000 description 8
- 235000009854 Cucurbita moschata Nutrition 0.000 description 8
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 150000007524 organic acids Chemical class 0.000 description 8
- 235000015136 pumpkin Nutrition 0.000 description 8
- 244000126002 Ziziphus vulgaris Species 0.000 description 7
- 230000000845 anti-microbial effect Effects 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 6
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 235000013311 vegetables Nutrition 0.000 description 6
- 241000581835 Monodora junodii Species 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 102000006995 beta-Glucosidase Human genes 0.000 description 4
- 108010047754 beta-Glucosidase Proteins 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 210000004988 splenocyte Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010016952 Food poisoning Diseases 0.000 description 3
- 208000019331 Foodborne disease Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 3
- 240000006079 Schisandra chinensis Species 0.000 description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- -1 lacchurose Chemical class 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside RG2 Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241001134659 Lactobacillus curvatus Species 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- 229940093496 esculin Drugs 0.000 description 2
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 2
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 230000005965 immune activity Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- AGBCLJAHARWNLA-UHFFFAOYSA-N (20R)-ginsenoside Rg2 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C3C(C)(C)C(O)CCC3(C)C3C(C4(CCC(C4C(O)C3)C(C)(O)CCC=C(C)C)C)(C)C2)OC(CO)C(O)C1O AGBCLJAHARWNLA-UHFFFAOYSA-N 0.000 description 1
- RAQNTCRNSXYLAH-RFCGZQMISA-N (20S)-ginsenoside Rh1 Chemical compound O([C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RAQNTCRNSXYLAH-RFCGZQMISA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 1
- 102000030900 Cystinyl aminopeptidase Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000004267 EU approved acidity regulator Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- UZIOUZHBUYLDHW-MSJHMJQNSA-N Ginsenoside Rf Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@@H]2[C@](C)([C@@]3(C)[C@H]([C@@H](O)C2)[C@@H]([C@@](O)(CC/C=C(\C)/C)C)CC3)C1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 UZIOUZHBUYLDHW-MSJHMJQNSA-N 0.000 description 1
- RAQNTCRNSXYLAH-UHFFFAOYSA-N Ginsenoside Rh1 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(C3)C)(C)C1C(O)CC2C1(C)CCC(O)C(C)(C)C1C3OC1OC(CO)C(O)C(O)C1O RAQNTCRNSXYLAH-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- ZHQQRIUYLMXDPP-ZETCQYMHSA-N actinidine Chemical compound C1=NC=C(C)C2=C1[C@@H](C)CC2 ZHQQRIUYLMXDPP-ZETCQYMHSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- UZIOUZHBUYLDHW-XUBRWZAZSA-N ginsenoside Rf Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZIOUZHBUYLDHW-XUBRWZAZSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
- A23L21/11—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products obtained by enzymatic digestion of fruit or vegetable compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
- A23L21/12—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products derived from fruit or vegetable solids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/36—Freezing; Subsequent thawing; Cooling
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A23Y2220/67—
Abstract
Description
본 발명은 흑삼발효젤리 및 이의 제조방법에 관한 것으로, 보다 상세하게는 흑삼 유산균 발효액을 원료로 하므로 흑삼의 체내 흡수가 용이하며, 고유의 쓴 맛이 줄어 전 연령의 섭취가 용이한 흑삼발효젤리 및 이의 제조방법에 관한 것이다.The present invention relates to a black ginseng fermented jelly and a method for producing the same, more specifically, black ginseng fermentation broth as a raw material is easy to absorb the black ginseng in the body, the intrinsic bitter taste is reduced, easy to ingest black ginseng fermentation jelly and It relates to a manufacturing method thereof.
인삼은 가공 방법에 따라 수삼, 백삼, 태극삼 및 홍삼 등으로 분류된다. 일반적으로 훈증과 가공법에 따라 삼의 종류가 바뀌게 되고 그 기능성성분 또한 증가되는 것으로 보고되고 있다.Ginseng is classified into ginseng, white ginseng, taeguksam and red ginseng according to processing methods. In general, it is reported that the type of hemp is changed according to the fumigation and processing method and its functional ingredient is also increased.
2000년대 초부터 금산 지역을 중심으로 한약재의 수치법(修治法)의 일종인 아홉 번 찌고 아홉 번 말리는 이른바, 구증구포(九蒸九曝)의 원리를 이용하여 인삼을 찌는 가공법이 개발되었고, 수삼을 찌고 말리는 과정을 반복하여 색깔이 흑색을 띠게 되어 해당 과정을 통해 얻어진 삼을 흑삼(black ginseng)이라고 부르게 되었다.Since the early 2000s, a process of steaming ginseng was developed using the principle of nine steaming and nine drying, which is a kind of numerical method of Chinese medicine, focusing on Geumsan area. The process of steaming and drying was repeated, and the color became black. The ginseng obtained through the process was called black ginseng.
흑삼은 기존의 홍삼과는 외관 특성과 성분 면에서 차별화되고 Rg3를 비롯한 생리활성 성분들이 인삼보다 홍삼이 많고, 홍삼보다는 흑삼이 더 높은 것으로 알려져 있다. 이외에도 ginsenoside Re, Rf, Rg1, Rg2 및 Rh1의 함량 또한 다른 삼 제품보다 흑삼에서 그 함량이 증가되는 것으로 알려져 있다.It is known that black ginseng is differentiated from conventional red ginseng in terms of appearance characteristics and ingredients, and physiologically active ingredients including Rg3 are more red ginseng than ginseng, and black ginseng is higher than red ginseng. In addition, the content of ginsenoside Re, Rf, Rg1, Rg2 and Rh1 is also known to increase in black ginseng than other ginseng products.
이에 따라, 흑삼은 2012년 인삼산업법의 개정으로 기존의 수삼, 백삼, 태극삼, 홍삼 등에 추가하여 인삼류의 새로운 품목으로 지정되었다.Accordingly, the black ginseng was designated as a new item of ginseng in addition to the existing ginseng, white ginseng, taeguksam, and red ginseng by the revision of the ginseng industry law in 2012.
따라서, 최근 흑삼을 활용한 다양한 건강보조식품들, 흑삼 농축액, 흑삼 환. 흑삼차, 흑삼절편, 흑삼사탕 등 여러 제품들이 개발되어 시판되고 있으나, 흑삼 제품은 고유의 쓴맛과 고분자원료의 제약으로 섭취에 어려움이 있다.Therefore, a variety of health supplements recently utilized black ginseng, black ginseng concentrate, black ginseng ring. Black ginseng tea, black ginseng slices, black ginseng candy and other products have been developed and marketed, but black ginseng products are difficult to consume due to the inherent bitter taste and constraints of polymer raw materials.
따라서, 이와 같은 어려움을 개선하기 위해 한국공개특허 제10-2017-0103722호 “흑삼커피 및 이의 제조방법”에는 볶은 커피와 볶은 흑삼을 혼합하여 커피를 제조하는 제조방법이 출원되었다.Therefore, in order to improve such a difficulty, Korean Laid-Open Patent Publication No. 10-2017-0103722 “Black Ginseng Coffee and its Manufacturing Method” has been filed with a manufacturing method for preparing coffee by mixing roasted coffee and roasted black ginseng.
그러나, 상기 한국공개특허 제10-2017-0103722호 “흑삼커피 및 이의 제조방법”에 의하면, 커피의 경우 노인과 어린이가 섭취하기에는 바람직하지 않아 남녀노소 모두의 섭취가 용이하지 않다는 문제점이 발생하였다.However, according to Korean Patent Laid-Open Publication No. 10-2017-0103722 "Black ginseng coffee and its manufacturing method", the coffee is not preferable for the elderly and children intake, the problem is that the intake of both age and sex is not easy.
본 발명은 상기와 같은 문제점을 해결하기 위해 창안된 것으로서, 흑삼 유산균 발효액을 원료로 하므로 흑삼의 체내 흡수가 용이하며, 고유의 쓴 맛이 줄어 전 연령의 섭취가 용이한 흑삼발효젤리 및 이의 제조방법을 제공하는 데 그 목적이 있다.The present invention was devised to solve the above problems, the black ginseng lactic acid bacteria fermentation broth as a raw material is easy to absorb in the body of black ginseng, the intrinsic bitter taste is reduced, easy to consume for all ages, black ginseng fermented jelly and its manufacturing method The purpose is to provide.
상기 과제를 해결하기 위해 본 발명은The present invention to solve the above problems
흑삼분말액에 기탁번호 KFCC11812P인 Lactobacillus plantarum SRCM 102370을 접종하여 흑삼 분말액을 발효시킨 후 발효된 흑삼 분말액을 살균 및 냉각시켜 흑삼 유산균 발효액을 제조하는 발효액 준비단계;Fermentation broth preparation step of inoculating Lactobacillus plantarum SRCM 102370 with accession number KFCC11812P to black ginseng powder solution to ferment black ginseng powder solution, and then sterilizing and cooling the fermented black ginseng powder solution to produce black ginseng lactic acid fermentation broth;
부재료를 계량하여 준비하는 부재료 준비단계;A subsidiary material preparation step of measuring and preparing the subsidiary material;
상기 흑삼 유산균 발효액과 부재료를 혼합하여 혼합물을 제조하는 혼합단계;A mixing step of preparing a mixture by mixing the black ginseng lactic acid bacteria fermentation broth and an ingredient;
상기 혼합물을 교반하는 교반단계;A stirring step of stirring the mixture;
상기 교반된 혼합물을 포장용기에 충진한 후 살균시키는 충진단계 및A filling step of sterilizing and then filling the stirred mixture in a packaging container;
상기 살균된 혼합물을 냉각시켜 흑삼발효젤리를 제조하는 혼합물 냉각단계를 포함하는 흑삼발효젤리 제조방법을 제공한다.It provides a black ginseng fermentation jelly manufacturing method comprising a mixture cooling step of cooling the sterilized mixture to produce black ginseng fermentation jelly.
상술한 바와 같은 본 발명에 따른 흑삼발효젤리 제조방법에 있어서, 상기 부재료는 감미제, 효소스테비아, 수크랄로스, 식이섬유, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨 및 비타민 C를 포함하는 것을 특징으로 할 수 있다.In the method for producing black ginseng fermented jelly according to the present invention as described above, the subsidiary material includes sweetener, enzyme stevia, sucralose, dietary fiber, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate and vitamin C. It can be characterized by.
상술한 바와 같은 본 발명에 따른 흑삼발효젤리 제조방법에 있어서, 상기 감미제는 에리스리톨 및 락츄로스 중 하나인 것을 특징으로 할 수 있다.In the method for producing black ginseng fermented jelly according to the present invention as described above, the sweetener may be characterized in that one of erythritol and lacchurose.
상술한 바와 같은 본 발명에 따른 흑삼발효젤리 제조방법에 있어서, 상기 부재료는 홍삼농축액 및 식품첨가제를 더 포함하고, 상기 식품첨가제는, 정제수 및 농축액 중 하나 이상을 포함하는 것을 특징으로 할 수 있다.In the method for producing black ginseng fermented jelly according to the present invention as described above, the subsidiary material may further include a red ginseng concentrate and a food additive, and the food additive may include one or more of purified water and a concentrate.
상술한 바와 같은 본 발명에 따른 흑삼발효젤리 제조방법에 있어서, 상기 부재료는 요구르트향 분말을 더 포함하는 것을 특징으로 할 수 있다.In the method for producing black ginseng fermented jelly according to the present invention as described above, the subsidiary material may be characterized in that it further comprises a yogurt flavor powder.
상술한 바와 같은 본 발명에 따른 흑삼발효젤리 제조방법에 있어서, 흑삼발효젤리 제조방법은 상기 교반단계 이후, 상기 교반된 혼합물에 착향료를 첨가하는 착향료 첨가단계를 더 포함할 수 있다.In the method for producing black ginseng fermented jelly according to the present invention as described above, the method for producing black ginseng fermented jelly may further include a flavoring agent adding step of adding flavoring agent to the stirred mixture after the stirring step.
상술한 바와 같은 본 발명에 따른 흑삼발효젤리 제조방법에 있어서, 상기 부재료는 키위 및 파파야를 더 포함하는 것을 특징으로 할 수 있다.In the method for producing black ginseng fermented jelly according to the present invention as described above, the subsidiary material may further include kiwi and papaya.
다른 기술적 과제를 달성하기 위하여 본 발명은 상술한 바와 같은 본 발명에 따른 흑삼발효젤리 제조방법에 의해 제조되는 흑삼발효젤리를 제공하다.In order to achieve another technical problem, the present invention provides a black ginseng fermented jelly prepared by the method for producing black ginseng fermented jelly according to the present invention as described above.
상기와 같이 구성되는 본 발명에 따른 흑삼발효젤리 및 이의 제조방법에 의하면, 흑삼 유산균 발효액을 포함하여 흑삼 성분의 체내 흡수가 우수한 흑삼발효젤리를 제공할 수 있다.According to the black ginseng fermentation jelly according to the present invention configured as described above and a manufacturing method thereof, it is possible to provide a black ginseng fermentation jelly excellent in the body absorption of black ginseng components, including black ginseng lactic acid bacteria fermentation broth.
또한, 감미제로 에리스리톨을 포함하므로 저칼로리 흑삼발효젤리를 제공할 수 있다.In addition, since it contains erythritol as a sweetening agent, it is possible to provide a low calorie black fermented jelly.
또한, 감미제로 락츄로스를 포함하므로 유아, 임산부부터 노인까지 전 연령층에 안전하고, 대장균과 같은 유해세균의 성장을 억제하는 효과를 갖는 흑삼발효젤리를 제공할 수 있다.In addition, it contains lacchurose as a sweetener, and thus can provide black fermented jelly which is safe for all ages from infants, pregnant women to the elderly, and has the effect of inhibiting the growth of harmful bacteria such as Escherichia coli.
또한, 과채농축액을 첨가하여 남녀노소 누구나 섭취가 용이한 흑삼발효젤리를 제공할 수 있다.In addition, the addition of vegetable concentrate can provide black ginseng fermented jelly easy to ingested by all ages.
또한, 본 발명의 최종 발효소재는 젤리뿐만 아니라 기타 가공품의 제조 시 체내흡수율이 증대된 형태로 다양한 식품 분야에 적용시킬 수 있다,In addition, the final fermentation material of the present invention can be applied to various food fields in the form of increased body absorption in the manufacturing of not only jelly, but also other processed products,
도 1은 본 발명의 실시예에 따른 흑삼발효젤리 및 이의 제조방법의 순서도이다.
도 2는 본 발명의 실시예에 따른 흑삼발효젤리 및 이의 제조방법의 발효액 준비단계를 도시한 순서도이다.
도 3은 본 발명의 제1 실시예에 따른 흑삼발효젤리의 시험검사성적서이다.
도 4는 비교균주인 KCTC 3035와 SRCM 102226, SRCM 102370의 진세노사이드Rb1으로부터 Rg3와 CK로의 전환능을 확인한 TLC 분석 결과이다.
도 5는 발효시간에 따른 흑삼분말 농도별, 균주 접종농도별 pH 변화 그래프이다.
도 6은 발효시간에 따른 흑삼분말 농도별, 균주농도별 총산도 변화 그래프이다.
도 7은 발효시간에 따른 흑삼분말 농도별, 균주농도별 생균수 변화 그래프(Log CFU/mL)이다.
도 8은 비교예와 본 발명의 실시예의 유리아미노산의 함량을 비교한 결과 그래프이다.
도 9의 (a) 및 (b)는 비교예와 본 발명의 실시예에 따른 비장세포 생존율 변화 그래프(24시간 후)이다.
도 10의 (a) 및 (b)는 비교예와 본 발명의 실시예에 따른 Cy에 처리된 비장세포의 세포 증식율 변화 그래프(24시간 후)이다.
도 11의 (a) 및 (b)는 비교예와 본 발명의 실시예에 따른 YAC-1 세포 생존율 변화 그래프(24시간 후)이다.
도 12의 (a) 및 (b)는 비교예와 본 발명의 실시예에 따른 NA 세포 활성 변화 그래프(24시간 후)이다.1 is a flow chart of black ginseng fermented jelly and a method for producing the same according to an embodiment of the present invention.
Figure 2 is a flow chart showing the fermentation broth preparation step of the black ginseng fermentation jelly and its preparation method according to an embodiment of the present invention.
Figure 3 is a test report of the black fermented jelly according to the first embodiment of the present invention.
4 is a result of TLC analysis confirming the conversion of ginsenoside Rb1 to Rg3 and CK of the comparative strains KCTC 3035,
Figure 5 is a graph of pH change by black ginseng powder concentration, strain inoculation concentration according to fermentation time.
6 is a graph showing the change in total acidity of black ginseng powder concentration and strain concentration according to fermentation time.
Figure 7 is a graph showing the change in viable cell number (Log CFU / mL) by the concentration of black ginseng powder, strain concentration according to fermentation time.
8 is a graph showing a result of comparing the content of the free amino acid of the comparative example and the embodiment of the present invention.
(A) and (b) of FIG. 9 are graphs showing changes in splenocyte viability according to Comparative Examples and Examples of the present invention (after 24 hours).
10 (a) and 10 (b) are graphs showing changes in cell proliferation rate of splenocytes treated with Cy according to a comparative example and an embodiment of the present invention (after 24 hours).
(A) and (b) of FIG. 11 are graphs showing changes in YAC-1 cell viability according to the comparative example and the embodiment of the present invention (after 24 hours).
12 (a) and (b) are graphs showing changes in NA cell activity according to the comparative example and the embodiment of the present invention (after 24 hours).
이하, 도면을 참조한 본 발명의 설명은 특정한 실시 형태에 대해 한정되지 않으며, 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있다. 또한, 이하에서 설명하는 내용은 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.Hereinafter, the description of the present invention with reference to the drawings is not limited to the specific embodiments, various changes may be made and various embodiments may be provided. In addition, the contents described below should be understood to include all transformations, equivalents, and substitutes included in the spirit and technical scope of the present invention.
본 발명에서 사용되는 기술적 용어는 단지 특정한 실시 예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아님을 유의해야 하고, 본 발명에서 사용되는 기술적 용어는 본 발명에서 특별히 다른 의미로 정의되지 않는 한, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 의미로 해석되어야 하며, 과도하게 포괄적인 의미로 해석되거나, 과도하게 축소된 의미로 해석되지 않아야 한다. Technical terms used in the present invention are merely used to describe specific embodiments, and it should be noted that they are not intended to limit the present invention, and technical terms used in the present invention are not specifically defined in the present invention. Unless otherwise, the present invention should be construed in the sense generally understood by those skilled in the art, and should not be construed in an excessively inclusive sense or in an excessively reduced sense.
또한, 본 발명에서 사용되는 기술적인 용어가 본 발명의 사상을 정확하게 표현하지 못하는 잘못된 기술적 용어일 때에는, 당 업자가 올바르게 이해할 수 있는 기술적 용어로 대체되어 이해되어야 할 것이다. 또한, 본 발명에서 사용되는 일반적인 용어는 사전에 정의되어 있는 바에 따라, 또는 전후 문맥상에 따라 해석되어야 하며, 과도하게 축소된 의미로 해석되지 않아야 한다. 본 발명에서 사용되는 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 또한, 이하에서 기재되는 "포함하다", "구비하다" 또는 "가지다" 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것으로 해석되어야 하며, 하나 또는 그 이상의 다른 특징들이나, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.In addition, when the technical terminology used in the present invention is an incorrect technical term that does not accurately express the spirit of the present invention, it should be replaced with a technical term that can be properly understood by those skilled in the art. In addition, the general terms used in the present invention should be interpreted as defined in the dictionary or according to the context before and after, and should not be interpreted in an excessively reduced sense. As used herein, the singular forms "a", "an" and "the" include plural forms unless the context clearly indicates otherwise. In addition, the terms "comprise", "comprise" or "have" described below are intended to designate that the features, numbers, steps, operations, components, parts, or combinations thereof described in the specification exist. It is to be understood that it does not exclude in advance the possibility of the presence or the addition of one or more other features or numbers, steps, actions, components, parts or combinations thereof.
이하, 본 발명의 바람직한 실시 예에 따른 흑삼발효젤리 및 이의 제조방법에 대하여 첨부한 도 1 내지 3을 참조하면서 상세하게 설명하기로 한다.Hereinafter, the black ginseng fermented jelly and its preparation method according to a preferred embodiment of the present invention will be described in detail with reference to FIGS.
도 1은 본 발명의 실시예에 따른 흑삼발효젤리 및 이의 제조방법의 순서도, 도 2는 본 발명의 실시예에 따른 흑삼발효젤리 및 이의 제조방법의 발효액 준비단계를 도시한 순서도, 도 3은 본 발명의 제1 실시예에 따른 흑삼발효젤리의 시험검사성적서이다.1 is a flow chart of black ginseng fermented jelly and a method for producing the same according to an embodiment of the present invention, Figure 2 is a flow chart showing the fermentation broth preparation step of the fermentation broth of black ginseng according to an embodiment of the present invention, Figure 3 This is a test report of black ginseng fermentation jelly according to the first embodiment of the present invention.
본 발명의 제1 실시예에 따른 흑삼발효젤리 제조방법은 도 1 내지 3에 도시된 바와 같이, 발효액 준비단계(S100), 부재료 준비단계(S200), 혼합단계(S300), 교반단계(S400), 충진단계(S600) 및 혼합물 냉각단계(S700)를 포함할 수 있다.Black ginseng fermentation jelly manufacturing method according to a first embodiment of the present invention, as shown in Figures 1 to 3, fermentation broth preparation step (S100), subsidiary material preparation step (S200), mixing step (S300), stirring step (S400) It may include a filling step (S600) and the mixture cooling step (S700).
먼저, 발효액 준비단계(S100)는 유산균을 이용해 흑삼 분말액을 배양시켜 유산균 발효액을 준비하는 단계로 배양단계(S110) 및 발효액 제조단계(S120)를 포함할 수 있다.First, the fermentation broth preparation step (S100) may include a culture step (S110) and a fermentation broth manufacturing step (S120) to prepare a fermentation broth of lactic acid bacteria by culturing the black ginseng powder solution using lactic acid bacteria.
배양단계(S110)는 유산균을 배양하여 흑삼 분말액을 발효시키는 단계로, 이때 유산균은 프로바이오틱스 활성(내산성, 내담즙성 등) 및 효소활성이 확보된 것이며, 또한 우수한 항균활성을 나타내는 것으로서 한국미생물보존센터에 2018년 12월 12일 기탁된 기탁번호 KFCC11812P인 Lactobacillus plantarum SRCM 102370이다.The culturing step (S110) is a step of fermenting black ginseng powder solution by culturing lactic acid bacteria, wherein the lactic acid bacteria have probiotic activity (acid resistance, bile resistance, etc.) and enzyme activity are secured, and also exhibit excellent antimicrobial activity. The center is Lactobacillus plantarum SRCM 102370, accession number KFCC11812P, deposited December 12, 2018.
상기 Lactobacillus plantarum SRCM 102370은 (재)발효미생물산업진흥원에서 알타리 김치로부터 분리 배양하여 확립된 균주로서 서열 상동성 검색 결과 Lactobacillus plantarum임을 확인하였으며, 특이적으로 내산성, 내담즙성 및 효소활성이 우수하고, 항균활성으로 식중독 유해 미생물에 대한 억제능이 우수하고, 진세노사이드를 전환시킬 수 있으며, 흑삼에 대한 발효 적성이 우수하다.The Lactobacillus plantarum SRCM 102370 was identified as Lactobacillus plantarum as a strain established by separating and cultivating from Altari kimchi at the (R) Fermentation Microbial Industry Promotion Agency. Specifically, it has excellent acid resistance, bile resistance and enzymatic activity, and has antibacterial activity, which is excellent in inhibiting food poisoning harmful microorganisms, can convert ginsenosides, and has good fermentation ability against black ginseng.
더욱 자세하게는, 1~2% 흑삼분말액에 유산균을 첨가한 후 30~45℃ 온도, 40~55시간 동안 발효시키며, 바람직하게는, 1% 흑삼분말액에 유산균을 첨가한 후 37℃ 온도에서 48시간 동안 발효시킬 수 있다.More specifically, lactic acid bacteria are added to 1-2% black ginseng powder solution and then fermented at 30-45 ° C. temperature for 40-55 hours. Preferably, lactic acid bacteria are added to 1% black ginseng powder solution at 37 ° C. It can be fermented for 48 hours.
유산균은, 흑삼 분말액을 발효시켜 큰 사포닌 분자를 Rg3, Rh1, Rh2 등과 같은 작은 사포닌 분자로 분해하므로 흑삼 고유의 기능성 성분을 체내에 용이하게 흡수시킬 수 있다.Lactic acid bacteria ferment the black ginseng powder solution to break down large saponin molecules into small saponin molecules such as Rg3, Rh1, Rh2, etc., so that the functional ingredients unique to black ginseng can be easily absorbed into the body.
1% 흑삼분말액은 분말액 방식으로 추출한 흑삼 성분이 1% 함유된 추출액이며, 상기 분말액은 건흑삼을 미세한 입자로 분말하여 이 중 1% 중량의 분말을 정제수와 혼합한 분말액을 의미한다.1% black ginseng powder solution is an extract containing 1% of black ginseng components extracted by the powder solution method, and the powder solution refers to a powder solution obtained by mixing dry black ginseng into fine particles and mixing 1% weight powder with purified water. .
이에 따라, 종래의 추출법과 다르게 흑삼을 물에 달이지 않고 통째로 갈은 흑삼을 첨가하므로 불용성 영양소를 용이하게 섭취할 수 있을 뿐만 아니라 섭취율이 증가되는 효과를 가진다.Accordingly, unlike the conventional extraction method, black ginseng is added to the whole without adding black ginseng to water, so that the insoluble nutrients can be easily ingested and the intake rate is increased.
또한, 흑삼을 건조시키는 과정에서 상품성이 떨어진 제품을 분말화하여 원료로 사용하므로 경제적 손실을 절감시킬 수 있다.In addition, in the process of drying black ginseng, the product is less commercially available powdered to use as a raw material can reduce the economic loss.
이때, 흑삼분말액의 성분이 1% 미만 함유될 경우, 유산균의 생육이 원활하지 않으며, 2%를 초과할 경우, 유산균의 생육 활성에 큰 차이가 발생하지 않아 비효율적이라는 문제점이 발생할 수 있다.At this time, when less than 1% of the components of the black ginseng powder, the growth of lactic acid bacteria is not smooth, if the content exceeds 2%, there is a problem that the large efficiency does not occur in the growth activity of lactic acid bacteria may be inefficient.
또한, 발효 온도가 30℃ 미만일 경우, 유산균의 생육이 원활하지 않으며, 45℃를 초과할 경우, 유산균이 사멸할 수 있다는 문제점이 발생할 수 있다.In addition, when the fermentation temperature is less than 30 ℃, the growth of lactic acid bacteria is not smooth, if the temperature exceeds 45 ℃, may cause problems that the lactic acid bacteria can be killed.
또한, 발효 시간이 40시간 미만일 경우, 유산균의 생육이 원활하지 않으며, 55시간을 초과할 경우, 과발효가 일어나 유산생성이 증가하는 등 목표하는 품질과의 차이를 유발할 수 있다.In addition, when the fermentation time is less than 40 hours, the growth of lactic acid bacteria is not smooth, and when more than 55 hours, over fermentation occurs, lactic acid production may increase, causing differences with the target quality.
이에 따르면, 하기 [실험예 1]에 기재된 바와 같이, 발효 완료 시 흑삼 유산균 발효액 내의 유산균이 108 CFU/ml로 높은 유산균 수치를 나타내므로 흑삼 고유의 기능성 성분을 체내에 효과적으로 흡수시키는 효과를 가진다.According to this, as described in the following [Experimental Example 1], when the fermentation is completed, lactic acid bacteria in the black ginseng lactic acid bacteria fermentation broth shows a high lactic acid bacteria value of 10 8 CFU / ml has the effect of effectively absorbing the functional ingredients unique to black ginseng in the body.
발효액 제조단계(S120)는 배양단계(S110)에 의해 발효된 흑삼 분말액을 살균 및 냉각시켜 흑삼 유산균 발효액을 제조하는 단계로, 더욱 자세하게는, 발효된 흑삼 분말액을 80~90℃ 온도로 가열하여 15~30분 동안 살균한 후, 45~55℃ 온도에서 냉각시키며, 바람직하게는 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시킬 수 있다.Fermentation broth production step (S120) is a step of producing a black ginseng lactic acid bacteria fermentation by sterilizing and cooling the black ginseng powder solution fermented by the culture step (S110), more specifically, the fermented black ginseng powder solution is heated to a temperature of 80 ~ 90 ℃ After sterilization for 15 to 30 minutes, it is cooled at 45 ~ 55 ℃ temperature, preferably sterilized by heating to 85 ℃ temperature can be cooled at 50 ℃ temperature.
이때, 살균 온도는 제품의 pH를 고려한 살균온도로 85℃, 30분을 최대 온도와 시간으로 설정하여 제품 성상에 차이가 나타나지 않게 하는 것을 목적으로 한다.At this time, the sterilization temperature is the sterilization temperature in consideration of the pH of the product is set to 85 ℃, 30 minutes to the maximum temperature and time for the purpose of preventing the difference in product properties.
또한, 냉각 온도가 45℃ 미만일 경우, 젤리 제조 시 공기 중에 부유하는 잡균의 오염 우려가 있고, 55℃를 초과할 경우, 충분히 냉각되어 비효율적이라는 문제점이 발생할 수 있다.In addition, when the cooling temperature is less than 45 ℃, there is a fear of contamination of various bacteria floating in the air during jelly production, if it exceeds 55 ℃, may cause a problem that it is sufficiently cooled and inefficient.
이에 따르면, 이후 흑삼발효젤리 제조 시 추가 발효가 발생하지 않아 균일한 품질을 가지는 흑삼발효젤리를 제조할 수 있다.According to this, there is no additional fermentation occurs when the black ginseng fermentation jelly is produced can be produced black ginseng fermentation jelly with a uniform quality.
다음으로, 부재료 준비단계(S200)는 부재료를 준비하는 단계로, 이때 부재료는 감미제, 효소스테비아, 수크랄로스, 식이섬유, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨 및 비타민 C를 포함할 수 있다.Next, the subsidiary material preparation step (S200) is a step for preparing the subsidiary material, wherein the subsidiary material is a sweetener, enzyme stevia, sucralose, dietary fiber, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate and vitamin C. It may include.
이때, 감미제는 당도 조절을 위해 저칼로리 에리스리톨을 포함하며, 이에 따라, 설탕 등이 포함된 기존의 젤리에 비해 낮은 칼로리를 가지는 흑삼발효젤리를 제조할 수 있다.At this time, the sweetener includes a low calorie erythritol to control the sugar content, and thus, it is possible to prepare a black ginseng fermented jelly having a lower calorie than conventional jelly including sugar.
또한, 식이섬유로는 난소화성말토덱스트린을 포함하며, 이에 따라, 원활한 배변활동을 돕는 흑삼발효젤리를 제조할 수 있다.In addition, the dietary fiber includes an indigestible maltodextrin, thereby producing a black ginseng fermented jelly to help smooth bowel activity.
또한, 기존의 한천 대신 곤약가루를 첨가하여 탱글한 식감이 극대화된 흑삼발효젤리를 제조할 수 있다.In addition, by adding konjac powder instead of the existing agar can be produced black ginseng fermented jelly maximized the texture.
다음으로 혼합단계(S300)는 발효액 준비단계(S100)에서 준비된 흑삼 유산균 발효액과 부재료 준비단계(S200)에서 준비된 부재료를 혼합하여 혼합물을 제조하는 단계로, 흑삼 유산균 발효액 90~92중량부, 감미제 5~6중량부, 효소 스테비아 0.005~0.015중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 1.8~2.2중량부, 곤약가루 0.05~0.15중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.13~0.17중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.03~0.09중량부를 포함할 수 있다.Next, the mixing step (S300) is a step of preparing a mixture by mixing the black ginseng lactic acid bacteria fermentation broth prepared in the fermentation broth preparation step (S100) and the raw materials prepared in the subsidiary material preparation step (S200), 90 ~ 92 parts by weight of black ginseng lactic acid fermentation broth,
더욱 자세하게는 흑삼 유산균 발효액 91중량부, 에리스리톨 5.465중량부, 효소 스테비아 0.01중량부, 수크랄로스 0.025중량부, 난소화성말토덱스트린 2중량부, 곤약가루 0.1중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부, 구연산 0.15중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.05중량부를 포함할 수 있다.More specifically, 91 parts by weight of black ginseng lactic acid bacteria fermentation broth, 5.465 parts by weight of erythritol, 0.01 parts by weight of enzyme stevia, 0.025 parts by weight of sucralose, 2 parts by weight of indigestible maltodextrin, 0.1 parts by weight of konjac powder, 0.2 parts by weight of xanthan gum, 0.5 parts of locus beans gum Part, carrageenan may include 0.4 parts by weight, citric acid 0.15 parts by weight, trisodium citrate 0.1 parts by weight, vitamin C 0.05 parts by weight.
또한, 혼합물은 단 맛을 나타내는 당류인 감미제, 효소 스테비아, 수크랄로스, 혼합물을 젤리화 시키는 검류인 곤약가루, 잔탄검, 로커스콩검, 카라기난, 산도를 조절해주는 산도조절제인 구연산, 구연산삼나트륨, 비타민C를 각각 혼합하여 준비하는 것이 바람직하다.In addition, the mixture is sweet sugars, sugars, stevia, sucralose, konjac powder, xanthan gum, locust bean gum, carrageenan, and acidity regulators citric acid, trisodium citrate, and vitamin C. It is preferable to prepare by mixing each.
이때, 흑삼 유산균 발효액이 90중량부 미만일 경우, 흑삼 특유의 풍미가 저하되며, 92중량부를 초과할 경우, 특유의 쓴 맛이 나타나 소비자의 기호도가 감소한다는 문제점이 발생할 수 있다.At this time, when the black ginseng lactic acid bacteria fermentation broth is less than 90 parts by weight, the unique flavor of black ginseng is lowered, when exceeding 92 parts by weight, a unique bitter taste appears may cause a problem that the consumer's preference decreases.
또한, 단 맛을 나타내는 감미제, 효소 스테비아, 수크랄로스가 바람직한 중량부 미만일 경우, 흑삼 고유의 쓴 맛이 나타며, 바람직한 중량부를 초과할 경우, 단맛이 과해져 소비자의 기호도가 저하되는 문제점이 발생할 수 있다.In addition, when sweeteners, enzymes stevia and sucralose, which exhibit sweet taste, are less than the preferred parts by weight, the bitterness inherent in black ginseng may appear, and when it exceeds the preferred parts by weight, the sweetness may be excessive and the consumer's preference may decrease. .
또한, 식이섬유가 1.8중량부 미만일 경우, 배변활동 촉진 효과가 미미하며, 2.2중량부를 초과할 경우, 복통을 유발하는 문제점이 발생할 수 있다.In addition, when the dietary fiber is less than 1.8 parts by weight, the bowel activity promoting effect is insignificant, and when it exceeds 2.2 parts by weight, a problem that causes abdominal pain may occur.
또한, 젤리화 물질인 곤약가루, 잔탄검, 로커스콩검, 카라기난이 바람직한 중량부 미만일 경우, 젤리의 점도 증가 및 유화안전성 증진 효과가 미미하며, 바람직한 중량부를 초과할 경우, 젤리의 제형이 단단해져 소비자의 기호도가 저하되는 문제점이 발생할 수 있다.In addition, when the jelly material konjac powder, xanthan gum, locus bean gum, carrageenan is less than the preferred parts by weight, the viscosity of the jelly and the effect of improving the emulsion safety is insignificant. The problem that the degree of preference decreases may occur.
또한, 산도를 조절해주는 구연산, 구연산삼나트륨, 비타민C가 바람직한 중량부 미만일 경우, 흑삼 고유의 쓴 맛이 나타며, 바람직한 중량부를 초과할 경우, 신맛과 짠맛이 과해져 소비자의 기호도가 저하되는 문제점이 발생할 수 있다.In addition, when citric acid, trisodium citrate, and vitamin C, which adjust the acidity, are less than the preferred parts by weight, the bitterness of the black ginseng is inherent, and when it exceeds the preferred parts by weight, the acidity and salty taste are excessive, resulting in deterioration of consumer preference. This can happen.
즉, 상기와 같은 중량비의 최적 조건에 의하면 맛과 기호도가 현저히 증가된 흑삼발효젤리를 제조할 수 있다.That is, according to the optimum conditions of the weight ratio as described above can be produced black ginseng fermented jelly with a marked increase in taste and preference.
또한, 부재료는 흑삼발효젤리 특유의 쓴맛을 감소시키고, 원활한 소화를 돕기 위해 키위 2~3중량부, 파파야 3~4중량부를 더 포함할 수 있다.In addition, the subsidiary material may further include 2-3 parts by weight of kiwi and 3-4 parts by weight of papaya in order to reduce bitterness peculiar to black ginseng fermentation jelly and to help smooth digestion.
키위는, 단백질의 소화에 도움을 주는 단백질 분해 효소인 액티니딘이 풍부하게 함유되어 있어 소화불량을 방지하는 효과를 가진다.Kiwi is rich in actinidine, a proteolytic enzyme that aids in the digestion of proteins, and has an effect of preventing indigestion.
파파야는, 소화에 도품을 주는 파파인과 키모파파인이 풍부하게 함유되어 있어 소화를 돕고 변비를 완화시키는 효과를 가진다.Papaya is rich in papain and chemopapine, which give it a digestive effect, which helps digestion and relieves constipation.
이때, 키위가 2중량부 미만일 경우, 소화불량 방지 효과가 미미하며, 3중량부를 초과할 경우, 단맛이 과해져 소비자의 기호도가 저하되는 문제점이 발생할 수 있다.At this time, if the kiwi is less than 2 parts by weight, the indigestion prevention effect is insignificant, and if it exceeds 3 parts by weight, the sweetness is excessive, the consumer's preference may be reduced.
또한, 파파야가 3중량부 미만일 경우, 소화를 돕는 효과가 미미하며, 4중량부를 초과할 경우, 단맛이 과해져 소비자의 기호도가 저하되는 문제점이 발생할 수 있다. In addition, if papaya is less than 3 parts by weight, the digestive effect is insignificant, and if it exceeds 4 parts by weight, the sweetness is excessive, there may be a problem that the consumer's preference decreases.
다음으로, 교반단계(S400)는 혼합물을 가열 교반시키는 단계로, 당류와 검류를 먼저 혼합하여 첨가 한 후, 80~85℃ 온도에서 5~10분 동안 교반시키고, 이후 산도조절제와 흑삼 유산균 발효액, 식이섬유를 첨가하여 5~10분 동안 교반시킬 수 있다.Next, the stirring step (S400) is a step of heating and stirring the mixture, sugar and gum are first mixed and added, and then stirred for 5 to 10 minutes at 80 ~ 85 ℃ temperature, then acidity regulator and black ginseng lactic acid fermentation broth, Add dietary fiber and stir for 5-10 minutes.
이때, 교반 온도가 80℃ 미만일 경우, 혼합물이 제대로 혼합되지 않아 전체적인 품질이 저하되며, 85℃를 초과할 경우, 혼합물이 충분히 혼합되어 비효율적이라는 문제점이 발생할 수 있다.At this time, when the stirring temperature is less than 80 ℃, the mixture is not properly mixed, the overall quality is lowered, if it exceeds 85 ℃, the mixture is sufficiently mixed may cause a problem that inefficient.
또한, 교반 시간이 5분 미만일 경우, 혼합물이 제대로 혼합되지 않아 전체적인 품질이 저하되며, 10분을 초과할 경우, 혼합물이 충분히 혼합되어 비효율적이라는 문제점이 발생할 수 있다.In addition, if the stirring time is less than 5 minutes, the mixture is not mixed properly, the overall quality is lowered, if it exceeds 10 minutes, the mixture may be sufficiently mixed and may cause a problem of inefficiency.
다음으로, 충진단계(S600) 교반된 혼합물을 포장용기에 충진한 후 살균시키는 단계로, 바람직하게는 20g씩 포장용기에 충진한 후 80~90℃ 온도에서 살균시킬 수 있다.Next, the filling step (S600) is a step of sterilizing the mixture after filling into the packaging container, preferably 20g by filling the packaging container can be sterilized at 80 ~ 90 ℃ temperature.
이때, 살균 온도가 80℃ 미만일 경우, 혼합물의 살균이 충분히 발생하지 않으며, 90℃를 초과할 경우, 제품 성상이 달라질 수 있다.At this time, if the sterilization temperature is less than 80 ℃, the sterilization of the mixture does not occur sufficiently, if it exceeds 90 ℃, product properties may vary.
다음으로, 혼합물 냉각단계(S700)는 살균된 혼합물을 냉각시키켜 흑삼발효젤리를 제조하는 단계로, 15~25℃ 온도에서 냉각시키며, 바람직하게는 20℃ 온도에서 냉각시킬 수 있다.Next, the mixture cooling step (S700) is a step of cooling the sterilized mixture to produce a black sam fermentation jelly, it is cooled at a temperature of 15 ~ 25 ℃, preferably can be cooled at a temperature of 20 ℃.
다음으로, 본 발명의 제2 실시예에 따른 흑삼발효젤리 제조방법은, 부재료의 감미제인 에리스리톨을 노약자(어린이, 영유아, 노인)가 과다하게 복용할 경우 배탈 유발의 위험이 발생할 수 있으므로 노약자의 효과적인 섭취를 위해 감미제가 락츄로스로 형성될 수 있다.Next, the method for preparing black ginseng fermented jelly according to the second embodiment of the present invention is effective for the elderly because the risk of causing upset stomach may occur when the elderly (children, infants and the elderly) excessively use erythritol as a sweetener of the subsidiary material. Sweeteners may be formed into lacchurose for ingestion.
또한, 노약자가 용이하게 섭취할 수 있도록 흑삼 특유의 쓴 맛을 감소시키기 위해 혼합단계(S300)에서 제조되는 혼합물의 중량비가 제1 실시예와 상이할 수 있다.In addition, the weight ratio of the mixture prepared in the mixing step (S300) may be different from the first embodiment to reduce the bitter taste peculiar to black ginseng so that the elderly can easily ingest.
또한, 부재료 준비단계(S200)의 부재료로 홍삼농축액, 식품첨가제 및 요구르트향 분말을 더 포함하고, 교반단계(S400) 이후, 착향료 첨가단계(S500)를 더 포함할 수 있다.In addition, red ginseng concentrate, food additives and yogurt-flavored powder may further be included as a subsidiary material of the subsidiary material preparation step (S200), and after the stirring step (S400), a flavoring agent addition step (S500) may be further included.
이때, 이 외의 제조방법은 제1 실시예에 따른 흑삼발효젤리의 제조방법과 동일하므로 이에 대한 설명은 생략하기로 한다.At this time, the other manufacturing method is the same as the manufacturing method of the black ginseng fermentation jelly according to the first embodiment will be omitted.
먼저, 부재료 준비단계(S200)의 부재료는 감미제, 효소스테비아, 수크랄로스, 식이섬유, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨, 비타민 C, 홍삼농축액 및 식품첨가제를 포함할 수 있다.First, the subsidiary material preparation step (S200) may include a sweetener, enzyme stevia, sucralose, dietary fiber, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate, vitamin C, red ginseng concentrate and food additives. have.
이때, 감미제는 프로바이오틱스 제품으로 각광받고 있는 락츄로스를 포함할 수 있다.In this case, the sweetening agent may include lactose, which has been spotlighted as a probiotic product.
락츄로스는 우유 내에 존재하는 이탄당인 유당의 이성화체로서, 유아, 임산부부터 노인까지 전 연령층에 안전하고, 장내 비피더스균의 증식을 도와 과민성 대장 증상이나 만성 변비 등의 치료에 효과적이며, 대장균과 같은 유해세균의 성장을 억제하는 효과를 가진다.Lactose is an isomer of lactose, a peat sugar present in milk, safe for all ages from infants, pregnant women to the elderly, and is effective in the treatment of intestinal bifidus bacteria and for the treatment of irritable bowel symptoms and chronic constipation. Has the effect of inhibiting the growth of bacteria.
또한, 식품첨가제는 정제수 및 과채농축액 중 하나 이상을 포함하며, 이때, 정제수는 흑삼 유산균 발효액과 1:1비율로 첨가될 수 있다.In addition, the food additive includes one or more of purified water and vegetable concentrate, wherein the purified water may be added in a 1: 1 ratio with the black ginseng lactic acid fermentation broth.
또한, 과채농축액은 사과농축액, 포도농축액, 바나나농축액, 대추 및 호박농축액, 오미자농축액 중 하나를 포함하며, 이에 따라, 흑삼 특유의 쓴 맛이 감소하여 남녀노소 누구나 섭취가 용이한 흑삼발효젤리를 제공할 수 있다.In addition, fruit concentrates include apple concentrate, grape concentrate, banana concentrate, jujube and pumpkin concentrate, Schisandra chinensis concentrate, thus reducing the unique bitter taste of black ginseng to provide a black ginseng fermented jelly easy for all ages can do.
또한, 부재료 준비단계(S200)의 부재료는 요구르트향 분말을 더 포함할 수 있다.In addition, the subsidiary material of the subsidiary material preparation step S200 may further include a yoghurt flavor powder.
다음으로, 혼합단계(S300)는 발효액 준비단계(S100)에서 준비된 흑삼 유산균 발효액과 부재료 준비단계(S200)에서 준비된 부재료를 혼합하여 혼합물을 제조하는 단계로, 일 예로, 흑삼 유산균 발효액 85~90중량부, 락츄로스 0.3~0.7중량부, 효소 스테비아 0.02~0.04중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 0.5~1.5중량부, 곤약가루 0.05~0.15중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.15~0.25중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.03~0.09중량부, 정제수 85~90중량부, 홍삼농축액 0.05~0.15중량부, 과채농축액 7~11중량부를 포함할 수 있다.Next, the mixing step (S300) is a step of preparing a mixture by mixing the black ginseng lactic acid bacteria fermentation broth prepared in the fermentation broth preparation step (S100) and the raw material prepared in the subsidiary material preparation step (S200), for example, 85 ~ 90 weight of black ginseng lactic acid fermentation broth Part, lacchurose 0.3-0.7 parts by weight, enzyme stevia 0.02-0.04 parts, sucralose 0.02-0.03 parts, dietary fiber 0.5-1.5 parts, konjac flour 0.05-0.15 parts, xanthan gum 0.18-0.22 parts, locus bean gum 0.45 to 0.55 parts by weight, carrageenan 0.35 to 0.45 parts by weight, citric acid 0.15 to 0.25 parts by weight, trisodium citrate 0.08 to 0.12 parts by weight, vitamin C 0.03 to 0.09 parts by weight, purified water 85 to 90 parts by weight, red ginseng concentrate 0.05 to 0.15 parts by weight Part, may include 7 to 11 parts by weight of vegetable concentrate.
또한, 혼합물은 단 맛을 나타내는 당류인 락츄로스, 효소 스테비아, 수크랄로스, 혼합물을 젤리화 시키는 검류인 곤약가루, 잔탄검, 로커스콩검, 카라기난, 산도를 조절해주는 산도조절제인 구연산, 구연산삼나트륨, 비타민C를 각각 혼합하여 준비하는 것이 바람직하다.In addition, the mixture contains sugars such as lacchurose, enzyme stevia, sucralose, sweet gum powder, xanthan gum, locus bean gum, carrageenan, and citric acid, trisodium citrate, and vitamin C. It is preferable to prepare by mixing each.
이때, 과채농축액으로는 사과농축액, 포도농축액, 바나나농축액, 오미자농축액 중 하나가 포함될 수 있다.At this time, the fruit concentrate may include one of apple concentrate, grape concentrate, banana concentrate, Schisandra chinensis concentrate.
또한, 흑삼 유산균 발효액이 90중량부 미만일 경우, 흑삼 특유의 풍미가 저하되며, 92중량부를 초과할 경우, 특유의 쓴 맛이 나타나 소비자의 기호도가 감소한다는 문제점이 발생할 수 있다.In addition, when the black ginseng lactic acid bacteria fermentation broth is less than 90 parts by weight, the unique flavor of black ginseng is lowered, when exceeding 92 parts by weight, a unique bitter taste appears may cause a problem that the consumer's preference.
또한, 단 맛을 나타내는 락츄로스, 효소 스테비아, 수크랄로스가 바람직한 중량부 미만일 경우, 흑삼 고유의 쓴 맛이 나타며, 바람직한 중량부를 초과할 경우, 단맛이 과해져 소비자의 기호도가 저하되는 문제점이 발생할 수 있다.In addition, when lacchurose, enzyme stevia, sucralose, which represents sweet taste, is less than the preferred part by weight, the bitterness inherent in black ginseng may appear, and when it exceeds the preferred part by weight, the sweetness may be excessive and the consumer's preference may decrease. .
또한, 식이섬유가 0.5중량부 미만일 경우, 배변활동 촉진 효과가 미미하며, 1.5중량부를 초과할 경우, 복통을 유발하는 문제점이 발생할 수 있다.In addition, when the dietary fiber is less than 0.5 parts by weight, the bowel activity promoting effect is insignificant, when it exceeds 1.5 parts by weight, a problem that causes abdominal pain may occur.
또한, 정제수가 85중량부 미만일 경우, 흑삼 및 홍삼 고유의 쓴 맛이 나타나 소비자의 기호도가 저하되며, 90중량부를 초과할 경우, 농도가 낮아져 과채농축액 고유의 맛이 미미해질 수 있다.In addition, when the purified water is less than 85 parts by weight, the bitter taste inherent in black and red ginseng appears, the consumer's preference decreases, and when it exceeds 90 parts by weight, the concentration is lowered, the taste unique to the vegetable concentrate may be insignificant.
또한, 홍삼농축액이 0.05중량부 미만일 경우, 홍삼 특유의 풍미가 미미하며, 0.15중량부를 초과할 경우, 특유의 쓴 맛이 나타나 소비자의 기호도가 감소한다는 문제점이 발생할 수 있다.In addition, when the red ginseng concentrate is less than 0.05 parts by weight, the unique flavor of the red ginseng is insignificant, when it exceeds 0.15 parts by weight, a unique bitter taste appears may cause a problem that the consumer's preference.
또한, 과채농축액이 7중량부 미만일 경우, 과채농축액 고유의 맛이 느껴지지 않고, 11중량부를 초과할 경우, 단 맛이 증가할 뿐만 아니라 흑삼 고유의 향이 사라져 소비자의 기호도가 감소한다는 문제점이 발생할 수 있다.In addition, when the fruit concentrate is less than 7 parts by weight, the inherent taste of the fruit concentrate is not felt, and when it exceeds 11 parts by weight, not only the sweetness is increased but also the inherent aroma of black ginseng disappears, which may cause a problem of consumer preference. have.
또한, 혼합물은 요구르트향 분말을 0.3~0.7중량부를 더 포함하며, 바람직하게는 요구르트향 분말 0.5중량부를 더 포함할 수 있다.In addition, the mixture further comprises 0.3 to 0.7 parts by weight of the yogurt flavor powder, preferably may further comprise 0.5 parts by weight of yogurt flavor powder.
다른 예로, 과채농축액의 종류에 따라 정제수를 포함하지 않을 수도 있으며, 더욱 자세하게는, 흑삼 유산균 발효액 93~97중량부, 락츄로스 0.3~0.7중량부, 효소 스테비아 0.02~0.06중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 0.5~1.5중량부, 곤약가루 0.05~0.15중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.15~0.25중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.03~0.09중량부, 홍삼농축액 0.05~0.15중량부, 과채농축액 93~97중량부를 포함할 수 있다.As another example, depending on the type of vegetable concentrate may not contain purified water, more specifically, 93 ~ 97 parts by weight of black ginseng lactobacillus fermentation broth, 0.3 ~ 0.7 parts by weight lactose, 0.02-0.06 parts by weight of enzyme stevia, 0.02-0.03 weight by sucralose Part, dietary fiber 0.5 to 1.5 parts by weight, konjac powder 0.05 to 0.15 parts, xanthan gum 0.18 to 0.22 parts, locus bean gum 0.45 to 0.55 parts, carrageenan 0.35 to 0.45 parts, citric acid 0.15 to 0.25 parts by weight, citric acid ginseng Sodium 0.08 ~ 0.12 parts by weight, vitamin C 0.03 ~ 0.09 parts by weight, red ginseng concentrate 0.05 ~ 0.15 parts by weight, vegetable concentrate may contain 93 to 97 parts by weight.
이때, 과채농축액으로는 대추 및 호박농축액이 포함되며, 대추 및 호박농축액은 정제수와 혼합 시 고유의 맛이 감소하므로 부재료에 정제수가 포함되지 않는 것이 바람직하다.At this time, the fruit concentrates include jujube and pumpkin concentrates, jujube and pumpkin concentrates are preferred because the inherent taste is reduced when mixed with purified water does not contain purified water.
또한, 흑삼 유산균 발효액이 93중량부 미만일 경우, 흑삼 특유의 풍미가 저하되며, 97중량부를 초과할 경우, 특유의 쓴 맛이 나타나 소비자의 기호도가 감소한다는 문제점이 발생할 수 있다.In addition, when the black ginseng lactobacillus fermentation broth is less than 93 parts by weight, the unique flavor of black ginseng is lowered, when exceeding 97 parts by weight, a unique bitter taste appears may cause a problem that the consumer's preference decreases.
또한, 과채농축액이 93중량부 미만일 경우, 과채농축액 고유의 맛이 느껴지지 않고, 97중량부를 초과할 경우, 흑삼 고유의 향이 사라져 소비자의 기호도가 감소한다는 문제점이 발생할 수 있다.In addition, if the fruit concentrate is less than 93 parts by weight, the taste unique to the fruit concentrate is not felt, if more than 97 parts by weight, the inherent aroma of black ginseng disappears may cause a problem that the consumer's preference decreases.
다음으로, 착향료 첨가단계(S500)는 교반된 혼합물에 착향료를 첨가하는 단계로, 더욱 자세하게는 0.5~1.5중량부를 포함하며, 바람직하게는, 1.0중량부를 포함할 수 있다.Next, the flavoring addition step (S500) is a step of adding a flavoring agent to the stirred mixture, more specifically, 0.5 to 1.5 parts by weight, preferably, may include 1.0 parts by weight.
또한, 착향료로는 천연사과향, 청사과향, 천연포도향, 청포도향, 바나나향, 천연바나나향 중 하나 이상이 포함될 수 있다.In addition, the flavoring agent may include one or more of natural apple flavor, green apple flavor, natural grape flavor, green grape flavor, banana flavor, natural banana flavor.
이때, 착향료가 0.5중량부 미만일 경우, 향이 미미하며, 1.5중량부를 초과할 경우, 흑삼 고유의 향이 사라져 소비자의 기호도가 감소한다는 문제점이 발생할 수 있다.At this time, when the flavoring agent is less than 0.5 parts by weight, the fragrance is insignificant, and when it exceeds 1.5 parts by weight, the inherent aroma of black ginseng disappears may cause a problem that the consumer's preference decreases.
이하에서 바람직한 예를 들어 흑삼발효젤리 조성물의 중량부에 대해 더욱 자세히 설명하기로 한다.Preferred examples will be described below in more detail with respect to the weight part of the black ginseng fermented jelly composition.
제1 예로, 흑삼 유산균 발효액 86~88중량부, 락츄로스 0.4~0.6중량부, 효소 스테비아 0.02~0.04중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 0.5~1.5중량부, 곤약가루 0.05~0.15중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.15~0.25중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.04~0.06중량부, 정제수 86~88중량부, 홍삼농축액 0.05~0.15중량부, 사과농축액 7~9중량부, 천연사과향 0.4~0.6중량부, 청사과향 0.4~0.6중량부를 포함할 수 있다.As a first example, 86 to 88 parts by weight of black ginseng lactic acid bacteria fermentation broth, 0.4 to 0.6 parts by weight of lactose, 0.02 to 0.04 parts by weight of enzyme stevia, 0.02 to 0.03 parts by weight of sucralose, 0.5 to 1.5 parts by weight of dietary fiber, 0.05 to 0.15 parts by weight of konjac powder , Xanthan gum 0.18 ~ 0.22 parts by weight, locus bean gum 0.45 ~ 0.55 parts by weight, carrageenan 0.35 ~ 0.45 parts by weight, citric acid 0.15 ~ 0.25 parts by weight, trisodium citrate 0.08 ~ 0.12 parts by weight, vitamin C 0.04 ~ 0.06 parts by weight, purified water 86 ~ 88 parts by weight, red ginseng concentrate 0.05 ~ 0.15 parts by weight, apple concentrate 7 ~ 9 parts by weight, natural apple flavor 0.4 ~ 0.6 parts, green apple flavor may include 0.4 ~ 0.6 parts by weight.
제2 예로, 흑삼 유산균 발효액 86~88중량부, 락츄로스 0.4~0.6중량부, 효소 스테비아 0.02~0.04중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 0.5~1.5중량부, 곤약가루 0.05~0.15중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.15~0.25중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.04~0.06중량부, 정제수 86~88중량부, 홍삼농축액 0.05~0.15중량부, 포도농축액 7~9중량부, 천연포도향 0.4~0.6중량부, 청포도향 0.4~0.6중량부를 포함할 수 있다.As a second example, 86 to 88 parts by weight of black ginseng lactic acid bacteria fermentation broth, 0.4 to 0.6 parts by weight of lactose, 0.02 to 0.04 parts by weight of enzyme stevia, 0.02 to 0.03 parts by weight of sucralose, 0.5 to 1.5 parts by weight of dietary fiber, and 0.05 to 0.15 parts by weight of konjac powder , Xanthan gum 0.18 ~ 0.22 parts by weight, locus bean gum 0.45 ~ 0.55 parts by weight, carrageenan 0.35 ~ 0.45 parts by weight, citric acid 0.15 ~ 0.25 parts by weight, trisodium citrate 0.08 ~ 0.12 parts by weight, vitamin C 0.04 ~ 0.06 parts by weight, purified water 86 ~ 88 parts by weight, red ginseng concentrate 0.05 ~ 0.15 parts by weight, grape concentrate 7 ~ 9 parts by weight, natural grapes may include 0.4 to 0.6 parts by weight, green grapes may include 0.4 to 0.6 parts by weight.
제3 예로, 흑삼 유산균 발효액 84~86중량부, 락츄로스 0.4~0.6중량부, 효소 스테비아 0.04~0.06중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 0.5~1.5중량부, 곤약가루 0.03~0.07중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.15~0.25중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.07~0.09중량부, 정제수 84~86중량부, 홍삼농축액 0.05~0.15중량부, 바나나농축액 9~10중량부, 요구르트향 분말 0.4~0.6중량부, 바나나향 0.4~0.6중량부, 천연바나나향 0.4~0.6중량부를 포함할 수 있다.Third, black ginseng lactic acid bacteria fermentation broth 84 ~ 86 parts by weight, lacchurose 0.4 ~ 0.6 parts by weight, enzyme stevia 0.04 ~ 0.06 parts by weight, sucralose 0.02 ~ 0.03 parts by weight, dietary fiber 0.5 ~ 1.5 parts by weight, konjac powder 0.03 ~ 0.07 parts by weight , Xanthan gum 0.18 ~ 0.22 parts by weight, locus bean gum 0.45 ~ 0.55 parts by weight, carrageenan 0.35 ~ 0.45 parts by weight, citric acid 0.15 ~ 0.25 parts by weight, trisodium citrate 0.08 ~ 0.12 parts by weight, vitamin C 0.07 ~ 0.09 parts by weight, purified water 84 ~ 86 parts by weight, red ginseng concentrate 0.05 ~ 0.15 parts by weight, banana concentrate 9 ~ 10 parts by weight, yogurt flavor powder 0.4 ~ 0.6 parts, banana flavor 0.4 ~ 0.6 parts, natural banana flavor may include 0.4 ~ 0.6 parts by weight. .
제4 예로, 흑삼 유산균 발효액 93~97중량부, 락츄로스 0.4~0.6중량부, 효소 스테비아 0.02~0.04중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 0.5~1.5중량부, 곤약가루 0.05~0.15중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.15~0.25중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.07~0.09중량부, 홍삼농축액 0.05~0.15중량부, 대추 및 호박 농축액 93~97중량부, 천연사과향 0.4~0.6중량부, 천연바나나향 0.4~0.6중량부를 포함할 수 있다.As a fourth example, 93 to 97 parts by weight of black ginseng lactic acid bacteria fermentation broth, 0.4 to 0.6 parts by weight of lactose, 0.02 to 0.04 parts by weight of enzyme stevia, 0.02 to 0.03 parts by weight of sucralose, 0.5 to 1.5 parts by weight of dietary fiber, and 0.05 to 0.15 parts by weight of konjac powder , Xanthan gum 0.18 ~ 0.22 parts by weight, locus bean gum 0.45 ~ 0.55 parts by weight, carrageenan 0.35 ~ 0.45 parts by weight, citric acid 0.15 ~ 0.25 parts by weight, trisodium citrate 0.08 ~ 0.12 parts by weight, vitamin C 0.07 ~ 0.09 parts by weight, red ginseng concentrate 0.05 to 0.15 parts by weight, jujube and pumpkin concentrate 93 to 97 parts by weight, natural apple flavor 0.4 to 0.6 parts by weight, natural banana flavor may include 0.4 to 0.6 parts by weight.
제5 예로, 흑삼 유산균 발효액 84~86중량부, 락츄로스 0.4~0.6중량부, 효소 스테비아 0.04~0.06중량부, 수크랄로스 0.02~0.03중량부, 식이섬유 0.5~1.5중량부, 곤약가루 0.05~0.15중량부, 잔탄검 0.18~0.22중량부, 로커스콩검 0.45~0.55중량부, 카라기난 0.35~0.45중량부, 구연산 0.15~0.25중량부, 구연산삼나트륨 0.08~0.12중량부, 비타민C 0.04~0.06중량부, 정제수 84~86, 홍삼농축액 0.05~0.15중량부, 오미자 농축액 9~11중량부, 청사과향 0.4~0.6중량부, 청포도향 0.4~0.6중량부를 포함할 수 있다.As a fifth example, 84 to 86 parts by weight of black ginseng lactic acid bacteria fermentation broth, 0.4 to 0.6 parts by weight of lactose, 0.04 to 0.06 parts by weight of enzyme stevia, 0.02 to 0.03 parts by weight of sucralose, 0.5 to 1.5 parts by weight of dietary fiber, and 0.05 to 0.15 parts by weight of konjac powder , Xanthan gum 0.18 ~ 0.22 parts by weight, locus bean gum 0.45 ~ 0.55 parts by weight, carrageenan 0.35 ~ 0.45 parts by weight, citric acid 0.15 ~ 0.25 parts by weight, trisodium citrate 0.08 ~ 0.12 parts by weight, vitamin C 0.04 ~ 0.06 parts by weight, purified water 84 ~ 86, 0.05 ~ 0.15 parts by weight of red ginseng concentrate, 9 ~ 11 parts by weight of Schizandra chinensis concentrate, 0.4 ~ 0.6 parts by weight of green apple flavor, 0.4 ~ 0.6 parts by weight of green grape flavor.
이하, 상기에서 설명한 실험예 및 실시예를 들어 본 발명을 더욱 구체적으로 설명하기로 한다. 그러나 본 발명이 반드시 이들 실험예 및 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the experimental examples and examples described above. However, the present invention is not necessarily limited to these experimental examples and examples.
[[ 제조예Production Example 1] One]
1% 흑삼분말액에 락토바실러스 플란타룸을 첨가한 후 37℃ 온도에서 48시간 동안 발효시켜 발효된 흑삼 분말액을 제조하였다.After adding Lactobacillus plantarum to 1% black ginseng powder solution, the fermented black ginseng powder solution was prepared by fermentation at 37 ° C. for 48 hours.
[[ 제조예Production Example 2] 2]
0.5% 흑삼분말액에 락토바실러스 플란타룸을 첨가한 후 37℃ 온도에서 48시간 동안 발효시켜 발효된 흑삼 분말액을 제조하였다.The fermented black ginseng powder solution was prepared by adding Lactobacillus plantarum to 0.5% black ginseng powder solution and then fermenting at 37 ° C. for 48 hours.
[[ 제조예3Preparation Example 3 ]]
3% 흑삼분말액에 락토바실러스 플란타룸을 첨가한 후 37℃ 온도에서 48시간 동안 발효시켜 발효된 흑삼 분말액을 제조하였다.Lactobacillus plantarum was added to the 3% black ginseng powder solution and then fermented at 37 ° C. for 48 hours to prepare fermented black ginseng powder solution.
[[ 제조예Production Example 4] 4]
5% 흑삼분말액에 락토바실러스 플란타룸을 첨가한 후 37℃ 온도에서 48시간 동안 발효시켜 발효된 흑삼 분말액을 제조하였다.The fermented black ginseng powder solution was prepared by adding Lactobacillus plantarum to 5% black ginseng powder solution and then fermenting at 37 ° C. for 48 hours.
[[ 실험예Experimental Example 1] 흑삼 유산균 발효액 내의 유산균 검사 1] Lactic acid bacteria test in black ginseng lactobacillus fermentation broth
유산균 생균수를 측정하기 위해 제조예 1 내지 4 5g을 45mL의 멸균증류수와 혼합한 후 균질시켜 10배 희석법으로 희석하였다. 총 유산균 수는 MRS 고체배지를 이용하였으며, 시료의 접종 후 37℃에서 48시간동안 배양시켜 측정하였다.In order to measure the number of lactic acid bacteria, 5 g of Preparation Examples 1 to 4 were mixed with 45 mL of sterile distilled water, homogenized, and diluted by a 10-fold dilution method. The total number of lactic acid bacteria was used for MRS solid medium, was measured by incubation for 48 hours at 37 ℃ after inoculation of the sample.
최종 발효물의 pH와 생균수 결과는 하기 [표 1]과 같다.PH and viable cell number of the final fermentation are shown in Table 1 below.
(not detected)-
(not detected)
유산균 접종 군에서 이상적인 발효가 일어날 경우, 발효 중 균이 생육됨과 동시에 산이 생성되고 최종 발효물의 pH가 낮아진다.이때, 상기 [표 1]의 결과를 보면, 제조예 4에서 발효 후 생균이 발견되지 않은 것으로 보아 유산균의 발효가 일어나지 않는 것을 알 수 있다.또한, 제조예 3은 제조예 1에 대비하여 높은 농도의 흑삼분말액이 첨가되나, 발효 후 생균수에서 큰 차이가 없으며 pH가 높은 값을 가지므로 제조예 3이 제조예 1보다 낮은 유산 생성능을 가지는 것을 알 수 있다.When the ideal fermentation occurs in the lactic acid bacteria inoculation group, bacteria are grown during fermentation, acid is generated, and pH of the final fermentation product is lowered. At this time, the results of Table 1 show that no viable bacteria were found after fermentation in Preparation Example 4. It can be seen that the fermentation of lactic acid bacteria does not occur. In addition, in Preparation Example 3, black ginseng powder of high concentration was added compared to Preparation Example 1, but there was no significant difference in viable cell count after fermentation, and had a high pH. Therefore, it can be seen that Preparation Example 3 has a lower lactic acid generating ability than Preparation Example 1.
이에 따라, 3% 흑삼분말액을 첨가하는 것 보다 1%의 흑삼분말액을 첨가하는 것이 바람직한 것을 알 수 있다.Accordingly, it can be seen that it is preferable to add 1% black ginseng powder rather than 3% black ginseng powder.
또한, 제조예 1은 제조예 2에 대비하여 발효 후 생균수가 현저히 높은 값을 가지므로 1%의 흑삼분말을 포함하는 본 발명의 흑삼발효젤리 유산균 함유량이 우수한 것을 알 수 있다.In addition, Preparation Example 1 has a significantly higher value of viable cell number after fermentation compared to Preparation Example 2, it can be seen that the content of the black ginseng fermented jelly lactic acid bacteria of the present invention containing 1% black ginseng powder.
[[ 실시예Example 1] One]
1% 흑삼분말액을 37℃ 온도에서 48시간 동안 발효시키고, 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시켜 흑삼 유산균 발효액을 제조하였다.1% black ginseng powder was fermented at 37 ° C. for 48 hours, sterilized by heating to 85 ° C., and cooled at 50 ° C. to prepare a black ginseng lactic acid fermentation broth.
에리스리톨, 효소스테비아, 수크랄로스, 난소화성말토덱스트린, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨 및 비타민 C를 부재료로 준비하였다. Erythritol, enzyme stevia, sucralose, indigestible maltodextrin, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate and vitamin C were prepared as submaterials.
에리스리톨 5.465중량부, 효소 스테비아 0.01중량부, 수크랄로스 0.025중량부를 혼합하여 당류 혼합물을 준비하고, 곤약가루 0.1중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부를 혼합하여 검류 혼합물을 준비하고, 구연산 0.15중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.05중량부를 혼합하여 산도조절제를 준비하고, 흑삼 유산균 발효액 91중량부, 난소화성말토덱스트린 2중량부를 준비하였다.5.465 parts by weight of erythritol, 0.01 part by weight of enzyme stevia and 0.025 part by weight of sucralose were prepared to prepare a saccharide mixture. Then, 0.15 parts by weight of citric acid, 0.1 parts by weight of trisodium citrate, and 0.05 parts by weight of vitamin C were mixed to prepare an acidity regulator, and 91 parts by weight of black ginseng lactic acid bacteria fermentation broth and 2 parts by weight of indigestible maltodextrin were prepared.
당류 혼합물과 검류 혼합물을 83℃온도에서 7분 동안 교반시킨 후, 산도조절제. 흑삼 유산균 발효액, 난소화성말토덱스트린 2중량부를 첨가하여 7분 동안 추가 교반시켰다.The sugar mixture and the gum mixture were stirred at 83 ° C. for 7 minutes, and then the acidity regulator. Black ginseng lactic acid bacteria fermentation broth, 2 parts by weight of indigestible maltodextrin was added and further stirred for 7 minutes.
20g씩 포장용기에 충진한 후 85℃ 온도에서 살균시키고, 살균된 혼합물을 20℃ 온도에서 냉각시켜 흑삼발효젤리를 제조하였다.After filling each 20g into a packaging container sterilized at 85 ℃ temperature, the sterilized mixture was cooled to 20 ℃ to prepare a black fermented jelly.
[[ 실시예Example 2] 2]
1% 흑삼분말액을 37℃ 온도에서 48시간 동안 발효시키고, 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시켜 흑삼 유산균 발효액을 제조하였다.1% black ginseng powder was fermented at 37 ° C. for 48 hours, sterilized by heating to 85 ° C., and cooled at 50 ° C. to prepare a black ginseng lactic acid fermentation broth.
락츄로스, 효소 스테비아, 수크랄로스, 난소화성말토덱스트린, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨, 비타민C, 정제수, 홍삼농축액, 사과농축액을 부재료로 준비하였다.Lactose, enzyme stevia, sucralose, indigestible maltodextrin, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate, vitamin C, purified water, red ginseng concentrate, and apple concentrate were prepared as subsidiary materials.
락츄로스 0.5중량부, 효소 스테비아 0.03중량부, 수크랄로스 0.025중량부를 혼합하여 당류 혼합물을 준비하고, 곤약가루 0.1중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부를 혼합하여 검류 혼합물을 준비하고, 구연산 0.2중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.05중량부를 혼합하여 산도조절제를 준비하고, 흑삼 유산균 발효액 87.795중량부, 난소화성말토덱스트린 1중량부, 정제수 87.795중량부, 홍삼농축액 0.1중량부, 사과농축액 8중량부를 준비하였다.A sugar mixture was prepared by mixing 0.5 parts by weight of lacchurose, 0.03 parts by weight of enzyme stevia, and 0.025 parts by weight of sucralose. Prepare a pH adjusting agent by mixing 0.2 parts by weight of citric acid, 0.1 parts by weight of trisodium citrate, and 0.05 parts by weight of vitamin C. 0.1 weight part and 8 weight part of apple concentrates were prepared.
당류 혼합물과 검류 혼합물을 83℃온도에서 7분 동안 교반시킨 후, 산도조절제. 흑삼 유산균 발효액, 난소화성말토덱스트린, 정제수, 홍삼농축액, 사과농축액을 첨가하여 7분 동안 추가 교반시켰다.The sugar mixture and the gum mixture were stirred at 83 ° C. for 7 minutes, and then the acidity regulator. Black ginseng lactobacillus fermentation broth, indigestible maltodextrin, purified water, red ginseng concentrate, apple concentrate were added and further stirred for 7 minutes.
20g씩 포장용기에 충진한 후 80~90℃ 온도에서 살균시켰다.20g each was packed in a packaging container and sterilized at 80 ~ 90 ℃ temperature.
살균된 혼합물에 천연사과향 0.5중량부, 청사과향 0.5중량부를 혼합한 후, 20℃ 온도에서 냉각시켜 흑삼발효젤리를 제조하였다.0.5 parts by weight of natural apple flavor and 0.5 parts by weight of green apple flavor were mixed with the sterilized mixture, and then cooled at 20 ° C. to prepare black ginseng fermented jelly.
[[ 실시예Example 3] 3]
1% 흑삼분말액을 37℃ 온도에서 48시간 동안 발효시키고, 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시켜 흑삼 유산균 발효액을 제조하였다.1% black ginseng powder was fermented at 37 ° C. for 48 hours, sterilized by heating to 85 ° C., and cooled at 50 ° C. to prepare a black ginseng lactic acid fermentation broth.
락츄로스, 효소 스테비아, 수크랄로스, 난소화성말토덱스트린, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨, 비타민C, 정제수, 홍삼농축액, 포도농축액을 부재료로 준비하였다.Lactose, enzyme stevia, sucralose, indigestible maltodextrin, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate, vitamin C, purified water, red ginseng concentrate, and grape concentrate were prepared as subsidiary materials.
락츄로스 0.5중량부, 효소 스테비아 0.03중량부, 수크랄로스 0.025중량부를 혼합하여 당류 혼합물을 준비하고, 곤약가루 0.1중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부를 혼합하여 검류 혼합물을 준비하고, 구연산 0.2중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.05중량부를 혼합하여 산도조절제를 준비하고, 흑삼 유산균 발효액 87.795중량부, 난소화성말토덱스트린 1중량부, 정제수 87.795중량부, 홍삼농축액 0.1중량부, 포도농축액 8중량부를 준비하였다.A sugar mixture was prepared by mixing 0.5 parts by weight of lacchurose, 0.03 parts by weight of enzyme stevia, and 0.025 parts by weight of sucralose. Prepare a pH adjusting agent by mixing 0.2 parts by weight of citric acid, 0.1 parts by weight of trisodium citrate, and 0.05 parts by weight of vitamin C. 0.1 weight part and 8 weight part of grape concentrates were prepared.
당류 혼합물과 검류 혼합물을 83℃온도에서 7분 동안 교반시킨 후, 산도조절제. 흑삼 유산균 발효액, 난소화성말토덱스트린, 정제수, 홍삼농축액, 포도농축액을 첨가하여 7분 동안 추가 교반시켰다.The sugar mixture and the gum mixture were stirred at 83 ° C. for 7 minutes, and then the acidity regulator. Black ginseng lactobacillus fermentation broth, indigestible maltodextrin, purified water, red ginseng concentrate, and grape concentrate were added and further stirred for 7 minutes.
20g씩 포장용기에 충진한 후 80~90℃ 온도에서 살균시켰다.20g each was packed in a packaging container and sterilized at 80 ~ 90 ℃ temperature.
살균된 혼합물에 천연포도향 0.5중량부, 청포도향 0.5중량부를 혼합한 후, 20℃ 온도에서 냉각시켜 흑삼발효젤리를 제조하였다.0.5 parts by weight of natural grape flavor and 0.5 parts by weight of green grape flavor were mixed with the sterilized mixture, and then cooled at 20 ° C. to prepare black ginseng fermented jelly.
[[ 실시예Example 4] 4]
1% 흑삼분말액을 37℃ 온도에서 48시간 동안 발효시키고, 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시켜 흑삼 유산균 발효액을 제조하였다.1% black ginseng powder was fermented at 37 ° C. for 48 hours, sterilized by heating to 85 ° C., and cooled at 50 ° C. to prepare a black ginseng lactic acid fermentation broth.
락츄로스, 효소 스테비아, 수크랄로스, 난소화성말토덱스트린, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨, 비타민C, 정제수, 홍삼농축액, 바나나농축액, 요구르트향 분말을 부재료로 준비하였다.Lactose, enzyme stevia, sucralose, indigestible maltodextrin, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate, vitamin C, purified water, red ginseng concentrate, banana concentrate, and yogurt flavor powder were prepared as ingredients.
락츄로스 0.5중량부, 효소 스테비아 0.05중량부, 수크랄로스 0.025중량부를 혼합하여 당류 혼합물을 준비하고, 곤약가루 0.05중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부를 혼합하여 검류 혼합물을 준비하고, 구연산 0.2중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.08중량부를 혼합하여 산도조절제를 준비하고, 흑삼 유산균 발효액 85.795중량부, 난소화성말토덱스트린 1중량부, 정제수 85.795중량부, 홍삼농축액 0.1중량부, 요구르트향 분말 0.5중량부, 바나나농축액 9.5중량부를 준비하였다.A sugar mixture was prepared by mixing 0.5 parts by weight of lacchurose, 0.05 parts by weight of enzyme stevia, and 0.025 parts by weight of sucralose. Prepare a pH adjusting agent by mixing 0.2 parts by weight of citric acid, 0.1 parts by weight of trisodium citrate, and 0.08 parts by weight of vitamin C. 0.1 parts by weight, 0.5 parts by weight of yogurt flavor powder, and 9.5 parts by weight of banana concentrate were prepared.
당류 혼합물과 검류 혼합물을 83℃온도에서 7분 동안 교반시킨 후, 산도조절제. 흑삼 유산균 발효액, 난소화성말토덱스트린, 정제수, 홍삼농축액, 요구르트향 분말, 바나나농축액을 첨가하여 7분 동안 추가 교반시켰다.The sugar mixture and the gum mixture were stirred at 83 ° C. for 7 minutes, and then the acidity regulator. Black ginseng lactobacillus fermentation broth, indigestible maltodextrin, purified water, red ginseng concentrate, yogurt flavor powder, banana concentrate was added and further stirred for 7 minutes.
20g씩 포장용기에 충진한 후 80~90℃ 온도에서 살균시켰다.20g each was packed in a packaging container and sterilized at 80 ~ 90 ℃ temperature.
살균된 혼합물에 바나나향 0.5중량부, 천연바나나향 0.5중량부를 혼합한 후, 20℃ 온도에서 냉각시켜 흑삼발효젤리를 제조하였다.0.5 parts by weight of banana flavor and 0.5 parts by weight of natural banana flavor were mixed with the sterilized mixture, and then cooled at 20 ° C. to prepare black fermented jelly.
[[ 실시예Example 5] 5]
1% 흑삼분말액을 37℃ 온도에서 48시간 동안 발효시키고, 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시켜 흑삼 유산균 발효액을 제조하였다.1% black ginseng powder was fermented at 37 ° C. for 48 hours, sterilized by heating to 85 ° C., and cooled at 50 ° C. to prepare a black ginseng lactic acid fermentation broth.
락츄로스, 효소 스테비아, 수크랄로스, 난소화성말토덱스트린, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨, 비타민C, 홍삼농축액, 대추 및 호박 농축액을 부재료로 준비하였다.Lactose, enzyme stevia, sucralose, indigestible maltodextrin, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate, vitamin C, red ginseng concentrate, jujube and pumpkin concentrate were prepared as subsidiary materials.
락츄로스 0.5중량부, 효소 스테비아 0.05중량부, 수크랄로스 0.025중량부를 혼합하여 당류 혼합물을 준비하고, 곤약가루 0.1중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부를 혼합하여 검류 혼합물을 준비하고, 구연산 0.2중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.08중량부를 혼합하여 산도조절제를 준비하고, 흑삼 유산균 발효액 95.745중량부, 난소화성말토덱스트린 1중량부, 홍삼농축액 0.1중량부, 대추 및 호박 농축액 95.745중량부를 준비하였다.A sugar mixture was prepared by mixing 0.5 parts by weight of lacchurose, 0.05 parts by weight of enzyme stevia, and 0.025 parts by weight of sucralose. Prepare a pH adjusting agent by mixing 0.2 parts by weight of citric acid, 0.1 parts by weight of trisodium citrate, and 0.08 parts by weight of vitamin C. And 95.745 parts by weight of pumpkin concentrate was prepared.
당류 혼합물과 검류 혼합물을 83℃온도에서 7분 동안 교반시킨 후, 산도조절제. 흑삼 유산균 발효액, 난소화성말토덱스트린, 홍삼농축액, 대추 및 호박 농축액을 첨가하여 7분 동안 추가 교반시켰다.The sugar mixture and the gum mixture were stirred at 83 ° C. for 7 minutes, and then the acidity regulator. Black ginseng lactobacillus fermentation broth, indigestible maltodextrin, red ginseng concentrate, jujube and pumpkin concentrate were added and further stirred for 7 minutes.
20g씩 포장용기에 충진한 후 80~90℃ 온도에서 살균시켰다.20g each was packed in a packaging container and sterilized at 80 ~ 90 ℃ temperature.
살균된 혼합물에 천연사과향 0.5중량부, 천연바나나향 0.5중량부를 혼합한 후, 20℃ 온도에서 냉각시켜 흑삼발효젤리를 제조하였다.0.5 parts by weight of natural apple flavor and 0.5 parts by weight of natural banana flavor were mixed with the sterilized mixture, and then cooled at 20 ° C. to prepare black ginseng fermented jelly.
[[ 실시예Example 6] 6]
1% 흑삼분말액을 37℃ 온도에서 48시간 동안 발효시키고, 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시켜 흑삼 유산균 발효액을 제조하였다.1% black ginseng powder was fermented at 37 ° C. for 48 hours, sterilized by heating to 85 ° C., and cooled at 50 ° C. to prepare a black ginseng lactic acid fermentation broth.
락츄로스, 효소 스테비아, 수크랄로스, 난소화성말토덱스트린, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨, 비타민C, 정제수, 홍삼농축액, 오미자 농축액을 부재료로 준비하였다.Lactose, enzyme stevia, sucralose, indigestible maltodextrin, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate, vitamin C, purified water, red ginseng concentrate, and schizandra concentrate were prepared as subsidiary materials.
락츄로스 0.5중량부, 효소 스테비아 0.03중량부, 수크랄로스 0.025중량부를 혼합하여 당류 혼합물을 준비하고, 곤약가루 0.1중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부를 혼합하여 검류 혼합물을 준비하고, 구연산 0.2중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.05중량부를 혼합하여 산도조절제를 준비하고, 흑삼 유산균 발효액 85.795중량부, 난소화성말토덱스트린 1중량부, 정제수 85.795중량부, 홍삼농축액 0.1중량부, 오미자 농축액 10중량부를 준비하였다.A sugar mixture was prepared by mixing 0.5 parts by weight of lacchurose, 0.03 parts by weight of enzyme stevia, and 0.025 parts by weight of sucralose. Prepare a pH adjusting agent by mixing 0.2 parts by weight of citric acid, 0.1 parts by weight of trisodium citrate, and 0.05 parts by weight of vitamin C. 0.1 weight part and 10 weight part of schizandra concentrate were prepared.
당류 혼합물과 검류 혼합물을 83℃온도에서 7분 동안 교반시킨 후, 산도조절제. 흑삼 유산균 발효액, 난소화성말토덱스트린, 정제수, 홍삼농축액, 오미자농축액을 첨가하여 7분 동안 추가 교반시켰다.The sugar mixture and the gum mixture were stirred at 83 ° C. for 7 minutes, and then the acidity regulator. Black ginseng lactobacillus fermentation broth, indigestible maltodextrin, purified water, red ginseng concentrate, Schisandra chinensis concentrate were added and further stirred for 7 minutes.
20g씩 포장용기에 충진한 후 80~90℃ 온도에서 살균시켰다.20g each was packed in a packaging container and sterilized at 80 ~ 90 ℃ temperature.
살균된 혼합물에 청사과향 0.5중량부, 청포도향 0.5중량부를 혼합한 후, 20℃ 온도에서 냉각시켜 흑삼발효젤리를 제조하였다.0.5 parts by weight of green apple flavor and 0.5 parts by weight of green grape flavor were mixed with the sterilized mixture, and then cooled at 20 ° C. to prepare black fermented jelly.
[[ 실시예Example 7] 7]
1% 흑삼분말액을 37℃ 온도에서 48시간 동안 발효시키고, 85℃ 온도로 가열하여 살균한 후 50℃ 온도에서 냉각시켜 흑삼 유산균 발효액을 제조하였다.1% black ginseng powder was fermented at 37 ° C. for 48 hours, sterilized by heating to 85 ° C., and cooled at 50 ° C. to prepare a black ginseng lactic acid fermentation broth.
에리스리톨, 효소스테비아, 수크랄로스, 난소화성말토덱스트린, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨, 비타민 C, 키위 및 파파야를 부재료로 준비하였다. Erythritol, enzyme stevia, sucralose, indigestible maltodextrin, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate, vitamin C, kiwi and papaya were prepared as submaterials.
에리스리톨 5.465중량부, 효소 스테비아 0.01중량부, 수크랄로스 0.025중량부를 혼합하여 당류 혼합물을 준비하고, 곤약가루 0.1중량부, 잔탄검 0.2중량부, 로커스콩검 0.5중량부, 카라기난 0.4중량부를 혼합하여 검류 혼합물을 준비하고, 구연산 0.15중량부, 구연산삼나트륨 0.1중량부, 비타민C 0.05중량부를 혼합하여 산도조절제를 준비하고, 흑삼 유산균 발효액 91중량부, 난소화성말토덱스트린 2중량부, 키위 2중량부, 파파야 3중량부를 준비하였다.5.465 parts by weight of erythritol, 0.01 part by weight of enzyme stevia and 0.025 part by weight of sucralose were prepared to prepare a saccharide mixture. Prepare the acidity regulator by mixing 0.15 parts by weight of citric acid, 0.1 parts by weight of trisodium citrate, 0.05 parts by weight of vitamin C, 91 parts by weight of black ginseng lactic acid fermentation broth, 2 parts by weight of indigestible maltodextrin, 2 parts by weight of kiwi,
당류 혼합물과 검류 혼합물을 83℃온도에서 7분 동안 교반시킨 후, 산도조절제. 흑삼 유산균 발효액, 난소화성말토덱스트린, 키위, 파파야를 첨가하여 7분 동안 추가 교반시켰다.The sugar mixture and the gum mixture were stirred at 83 ° C. for 7 minutes, and then the acidity regulator. Black ginseng lactobacillus fermentation broth, indigestible maltodextrin, kiwi and papaya were added and further stirred for 7 minutes.
20g씩 포장용기에 충진한 후 85℃ 온도에서 살균시키고, 살균된 혼합물을 20℃ 온도에서 냉각시켜 흑삼발효젤리를 제조하였다.After filling each 20g into a packaging container sterilized at 85 ℃ temperature, the sterilized mixture was cooled to 20 ℃ to prepare a black fermented jelly.
[[ 비교예Comparative example ]]
시중에서 판매중인 홍삼인 고려흑삼 젤리를 구매하여 준비하였다.Korean black ginseng jelly, commercially available red ginseng, was purchased and prepared.
[[ 실험예Experimental Example 2] 관능검사 2] sensory test
실시예에 따른 쓴맛, 신맛, 단맛, 향, 기호도를 측정하기 위해 실시예 1 내지 7 및 비교예를 준비하여 관능검사를 실시하였다.In order to measure bitterness, sourness, sweetness, aroma, and palatability according to the Examples, Examples 1 to 7 and Comparative Examples were prepared and sensory tests were performed.
패널은 성인 남자 20명, 성인 여자 20명을 선정하여 5점척도법(1: 매우 나쁨, 2: 나쁨, 3: 보통, 4: 좋음, 5: 매우 좋음)에 의하여 평가하였으며, 그 결과는 하기 [표 2]와 같다.The panel selected 20 adult males and 20 adult females and evaluated them by a five-point scale (1: very bad, 2: bad, 3: normal, 4: good, 5: very good). Table 2].
상기 [표 2]의 결과로 보아, 실시예의 신맛, 단맛, 향, 기호도가 비교예에 비해 우수함을 알 수 있으며, 쓴맛이 비교예에 비해 낮은 것을 알 수 있다.또한, 실시예 2 및 5의 기호도가 가장 높은 것을 알 수 있으며, 이에 따라, 사과농축액과 대추 및 호박 농축액을 포함하는 흑삼발효젤리의 맛, 향, 기호도가 가장 우수한 것을 알 수 있다.As a result of the above [Table 2], it can be seen that the sour taste, sweetness, aroma, preference of the Example is superior to the comparative example, and the bitter taste is lower than the comparative example. It can be seen that the highest degree of preference, and accordingly, it can be seen that the taste, aroma, and palatability of black ginseng fermented jelly including apple concentrate and jujube and pumpkin concentrate are the best.
이상에서 첨부된 도면을 참조하여 본 발명의 제1 및 제2 실시예를 설명하였으나, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에 의하여 다른 구체적인 형태로 실시할 수 있다는 것을 이해할 수 있을 것이다. 따라서 이상에서 기술한 제1 및 제2 실시예는 모든 면에서 예시적인 것이며 한정적이 아닌 것이다.Although the first and second embodiments of the present invention have been described above with reference to the accompanying drawings, it will be understood that the present invention may be embodied in other specific forms by those skilled in the art. . Accordingly, the first and second embodiments described above are exemplary in all respects and not restrictive.
이하에서는 흑삼 발효에 사용된 유산균인 기탁번호 KFCC11812P인 Lactobacillus plantarum SRCM 102370의 우수성 및 특성에 대한 실험 및 시험결과를 설명한다.Hereinafter, the experiment and test results for the superiority and characteristics of
[[ 실험예Experimental Example 3] 유산균의 최종 균주 선발 3] Selection of final strain of lactic acid bacteria
1. 균주 배양 및 보관1. Strain Culture and Storage
실험에 사용된 유산균주는 전라북도 순창군에 소재한 발효미생물진흥원에서 전통발효시료에서 분리한 유산균 총 14종과 비교균주로 한국미생물보존센터(KCCM), 한국생명공학연구원 생물자원센터(KCTC)에서 각 1종씩 분양받아 본 실험에 사용하였다. The lactic acid bacteria used in the experiment were 14 kinds of lactic acid bacteria isolated from traditional fermentation samples from the fermentation microorganism promotion center located in Sunchang-gun, Jeollabuk-do, and one each from the Korea Microorganism Conservation Center (KCCM) and the Korea Biotechnology Center (KCTC). It was used for this experiment.
확보된 균주는 MRS 액체배지에 1%씩 접종하여 37℃, 48시간 배양하여 사용하였고, 사용이 종료된 후에는 60% 글리세롤 용액과 함께 -70℃ deep freezer에 보관하였다.The obtained strain was inoculated in 1% by MRS liquid medium and incubated for 48 hours at 37 ℃, and after use was stored in a -70 ℃ deep freezer with 60% glycerol solution.
여기서, 비교균주는 호서대에서 진행한 발효인삼의 ginsenoside 유도연구에서 효과를 나타낸 Lactobacillus delbrueckii supsp. lactis KCTC 3035(KCTC 1058)와 발효산업미생물진흥원에서 항균활성 확인 시 사용하는 Lactobacillus plantarum KCCM 12116이고, 실험 과정 중 Negative control로 확보된 유산균 중 효소활성 및 발효능, 진세노사이드 전환등이 낮게 나타난 Lactobacillus curvatus SRCM 102226을 함께 참조균주로 설정하였다.Here, the comparative strain was Lactobacillus delbrueckii supsp. Which showed the effect in ginsenoside induction study of fermented ginseng conducted in Hoseo University. lactis KCTC 3035 (KCTC 1058) and Lactobacillus plantarum KCCM 12116, which is used to confirm antimicrobial activity in the Korea Fermentation Industry and Microorganism Agency.
2. 2. 프로바이오틱스Probiotics 활성 평가 Active evaluation
프로바이오틱스 활성을 평가하여 균주를 선별하기 위해 내산성, 내담즙성 및 항균활성을 하기와 같은 방법을 통해 평가하였다.In order to evaluate the probiotic activity, acid resistance, bile resistance and antimicrobial activity were evaluated by the following methods.
먼저 분양받은 유산균주와 비교균주를 MRS 배지에서 37℃, 24시간 배양하여 실험을 진행하였다. First, the cultured lactic acid bacteria and comparative strains were cultured in MRS medium at 37 ° C. for 24 hours.
내산성을 확인하기 위해 MRS 액체배지에 HCl와 NaOH를 이용하여 각각 pH 2.5와 7.0으로 조절한 후 37℃에서 3시간 진탕 배양한 후, 배양액을 0.85% 멸균 생리식염수로 연속 희석하여 MRS 고체배지에 도말하고 37℃, 48시간 배양하여 생균수를 측정하였다. pH 조절 전 생균수를 대조구로 생존률을 확인하여 내산성 정도를 확인하였다. In order to confirm acid resistance, the mixture was adjusted to pH 2.5 and 7.0 using HCl and NaOH in MRS liquid medium, and then shaken at 37 ° C. for 3 hours, followed by serial dilution of the culture solution with 0.85% sterile saline solution to smear the solid medium. And incubated for 48 hours at 37 ℃, the number of viable cells was measured. The viable cell count before pH adjustment was checked for viability by checking the survival rate.
내담즙성 분석은 MRS 액체배지에 담즙을 0.3% 첨가하여 37℃에서 3시간 진탕 배양한 후, 배양액을 0.85% 멸균 생리식염수로 연속 희석하여 MRS 고체배지에 도말하고 37℃, 48시간 배양하여 생균수를 측정하였다. 내담즙성은 담즙 첨가 전의 생균수를 대조구로 생존률을 확인하여 담즙성 정도를 확인하였다.In the analysis of the biliary resistance, 0.3% of bile was added to the MRS liquid medium, followed by shaking culture at 37 ° C for 3 hours, followed by serial dilution of the culture solution with 0.85% sterile saline solution, plated on MRS solid medium, and cultured at 37 ° C for 48 hours. The number was measured. The resistance to bile was confirmed by the viability of the viable cells prior to the addition of bile to confirm the degree of bile.
이때, 생존률은 하기 식을 통해 구하였다.At this time, the survival rate was obtained through the following equation.
생존률(%)=[생존균수(CFU/mL)/대조구(control) 균수(CFU/mL)]×100Survival rate (%) = [survival bacteria (CFU / mL) / control bacteria (CFU / mL)] × 100
병원균에 대한 항균활성을 측정하는 방법으로는 식품을 부패 또는 오염시켜 식중독을 유발하는 바실러스 세레우스와 스테필로코커스 아우레우스에 대한 항균활성을 측정하였다. 여기서, 실험균주로는 바실러스 세레우스 KCTC 3624, 스테필로코커스 아우레우스 KCCM 11593을 사용하였고, 실험은 발효미생물산업진흥원의 도움으로 진행되었다. 먼저 각 검정균이 자랄 수 있는 bottom agar(TSA, difco)를 제조한 후, 유산균주를 배지에 각각 접종한다. 이후 검정균을 1% 접종한 top agar(MRS)를 부어 말리고, 37℃, 48시간 경과 후 투명환의 크기를 측정하였다.As a method of measuring the antimicrobial activity against pathogens, the antimicrobial activity against Bacillus cereus and Staphylococcus aureus causing food poisoning by decaying or contaminating food was measured. Here, Bacillus cereus KCTC 3624, Staphylococcus aureus KCCM 11593 were used as the experimental strain, and the experiment was conducted with the aid of the Korea Fermentation Microorganism Industry Promotion Agency. First, a bottom agar (TSA, difco), in which each assay is grown, is prepared, and then the lactic acid bacteria are inoculated in the medium. After pour the top agar (MRS) inoculated with 1% of the assay bacteria, dried, and the size of the transparent ring was measured after 48 hours.
실험 결과, 유산균주 14종 중에서 Lactobacillus plantarum SRCM 102370(기탁번호 KFCC11812P)의 내산성, 내담즙성 및 항균활성에 대한 가장 우수한 활성을 확인할 수 있었다.As a result of the experiment, it was confirmed that among the 14 strains of Lactobacillus plantarum SRCM 102370 (Accession No. KFCC11812P), the best activity against acid resistance, bile resistance and antibacterial activity.
이때, Lactobacillus curvatus SRCM 102226는 내산성, 내담즙성 및 항균활성이 가장 낮게 나온 균주로 나와 참조균주로 사용하였다.At this time,
비교균주, Lactobacillus curvatus SRCM 102226(참조균주), Lactobacillus plantarum SRCM 102370의 내산성, 내담즙성 및 항균활성 결과는 하기 표 3 및 표 4와 같다.The results of acid resistance, bile resistance and antibacterial activity of the comparative strain, Lactobacillus curvatus SRCM 102226 (reference strain),
상기 표 3을 보면 알 수 있듯이, 최소한의 probiotics 활성을 확인한 내산성과 내담즙성을 검토한 결과, 비교균주 KCTC 3035와 참조균주 SRCM 102226는 pH 2.5에 노출 시, 유효숫자 미만으로 계수에 어려움이 있어 생존률이 낮은 것을 확인할 수 있었고, 비교균주 KCCM 12116은 생존률이 1.95%로 확인되었다. As can be seen from Table 3 above, as a result of examining acid resistance and bile resistance which confirmed the minimum probiotics activity, the
반면에, SRCM 102370 균주(기탁번호 KFCC11812P)는 pH 2.5에서 86.55%의 생존률이 확인되었고 게시한 결과를 포함한 모든 시험군에서 가장 우수한 생존력을 확인할 수 있었다. On the other hand,
이는 곧 pH 2.5의 조건에서 3시간 동안 SRCM 102370 균주가 86.55% 이상 생존하여 장으로 이동할 수 있을 것으로 판단된다. This is expected that
담즙산은 미생물의 세포막에 영향을 주어 미생물이 사멸하는 것으로 보고되었으나, SRCM 102370은 무처리군과 비교하여 그 값이 오히려 증가하는 것으로 확인되었다.The bile acid was reported to affect the cell membrane of the microorganisms to kill the microorganisms, but
또한, 표 4를 보면 알 수 있듯이, 구토와 설사 등을 유발하는 식중독 관련 병원성 미생물에 대한 항균활성의 측정을 선별한 분리균주를 대상으로 확인한 결과, SRCM 102370 균주(기탁번호 KFCC11812P)는 항균활성이 우수한 비교균주 KCCM 12116과 비교해 유사한 결과를 나타내고, 검정균주 3종에 대한 높은 활성을 보이고 있어 식중독 유해 미생물에 대한 억제능이 우수한 것으로 사료된다.In addition, as can be seen from Table 4, as a result of the screening of isolated strains selected for the measurement of the antimicrobial activity against food poisoning-related pathogenic microorganisms causing vomiting and diarrhea,
이에, 유산균주 중에서 내산성, 내담즙성 및 항균활성이 가장 우수한 Lactobacillus plantarum SRCM 102370을 1차 균주로 선별하였다.Therefore,
3. 효소활성 평가3. Enzyme Activity Evaluation
효소활성을 평가하여 최종균주를 선발하기 위해 하기와 같은 방법을 통해 세포 외 효소활성, API ZYM을 이용한 효소활성을 평가하였다.In order to evaluate the enzymatic activity and to select the final strain was evaluated by the following method extracellular enzyme activity, enzyme activity using API ZYM.
먼저, 1차로 선별된 1차 균주의 세포외 효소 활성 측정은 프로테아제와 베타글루코시데이즈에 대하여 조사하였고, 1% skim milk(Difco), 0.5% esculin(sigma)를 각각의 기질로 하여 well diffusion 방법을 이용하여 측정하였다.First, the measurement of extracellular enzyme activity of the first selected primary strain was examined for protease and betaglucosidase, and well diffusion method using 1% skim milk (Difco) and 0.5% esculin (sigma) as substrates. Measured using.
또한, 1차 균주의 효소 활성을 조사하기 위해 API ZYM kit(bioMerieux Co., Marcy-I'Etoile, France)를 사용하여 alkaline phosphatase 외 18가지 효소 활성을 검사하였다. 균주를 MRS 고체배지에서 배양하여 균체를 회수하고 멸균수에 3회 세척한 후 멸균수에 현탁하여 시료를 준비하였다. 현탁액 500 ul를 5 mL suspension medium에 풀어준 후 5~6 Mcfarland(bioMerieux Co.)로 탁도를 조정하였다. 탁도를 조정한 현택액을 ZYM kit의 각 큐플에 접종하여 37℃에서 4시간 배양한 후 표현 활성 증가와 용해를 도와주는 ZYM A, B 시약을 각각의 큐플에 한 방울씩 떨어뜨려 5분간 반응 후 색깔의 변화를 관찰하여 효소 활성 정도를 조사하였다. 이때, 색의 변화 정도에 따라 0~5까지의 값으로 표시하였으며, 0은 음성반응, 5 (≥40 nmoles)는 최대 강도의 반응이고 4~1은 각각 30, 20, 10, 5 nmoles의 중간 값을 나타내며 3 이상일 경우 양성으로 판정하였다.In addition, 18 enzyme activities including alkaline phosphatase were tested using API ZYM kit (bioMerieux Co., Marcy-I'Etoile, France) to investigate the enzyme activity of the primary strain. The strains were cultured in MRS solid medium to recover the cells, washed three times in sterile water and then suspended in sterile water to prepare a sample. After dissolving 500 ul of suspension in a 5 mL suspension medium, the turbidity was adjusted with 5-6 Mcfarland (bioMerieux Co.). After incubating the suspension with adjusted turbidity in each chaple of ZYM kit and incubating for 4 hours at 37 ° C, 5 minutes of reaction was performed by dropping ZYM A and B reagents to each chapel to help increase expression and dissolution. The degree of enzyme activity was examined by observing the change of color. At this time, it was expressed as a value from 0 to 5 according to the degree of color change, 0 is a negative reaction, 5 (≥40 nmoles) is the response of the maximum intensity, 4 ~ 1 is the middle of 30, 20, 10, 5 nmoles respectively A value of 3 or more was determined as positive.
비교균주와 1차 균주의 세포 외 효소활성 및 ZYM kit 결과는 하기 표 5 및 표 6과 같다.Extracellular enzyme activity and ZYM kit results of the comparative strain and the first strain are shown in Tables 5 and 6.
먼저, 표 5를 보면 알 수 있듯이, 비교균주인 KCTC 3035의 반응은 확인하기 어려웠고, KCCM 12116은 활성이 나타나긴 하였으나, SRCM 102370(기탁번호 KFCC11812P)의 활성이 가장 뛰어난 것을 확인하였으며, SRCM 102226은 반응이 나타나지 않는 것을 확인할 수 있었다.First, as can be seen in Table 5, the reaction of the
또한, 표 6을 보면 알 수 있듯이, ZYM kit를 이용해 추가 효소활성을 검토한 결과에서도 비교균주 및 SRCM 102226(참조균주)에 비해 SRCM 102370의 효소활성이 두드러지는 것을 확인할 수 있었다.In addition, as can be seen from Table 6, it was confirmed that the enzyme activity of
구체적으로, SRCM 102370는 ZYM kit를 통해 β-glucosidase 외에도 11종의 효소활성이 더 있는 것으로 관찰되었다. Specifically,
지방 분해에 관여하는 Esterase, Esterase lipase와 펩타이드 가수분해 효소인 Leucine arylamidase, Valine arylamidase, Cystine arylamidase 등에서 5~30 nmol의 활성을 나타내었고, 유당 분해에 관여하는 β-galactosidase는 가장 높은 40 nmol의 활성을 나타내었으며, ginsenoside 전환에 필요한 β-glucosidase의 활성은 30 nmol로 확인되었다.Esterase, Esterase lipase involved in lipolysis, and Leucine arylamidase, Valine arylamidase, Cystine arylamidase, which are peptide hydrolysates, showed 5-30 nmol activity. The β-glucosidase activity required for ginsenoside conversion was found to be 30 nmol.
참고로, 이는 SRCM102370의 ginsenoside 전환능을 확인하기 위한 하기 실험(4. Ginsenoside Rb1의 전환)에서 esculin iron agar로 실험한 결과 colony 주변에 검정색 환이 형성됨에 따라 β-glucosidase 활성이 나타난 결과를 뒷받침하고 있다.For reference, this test supports the results of β-glucosidase activity as a black ring was formed around colony as a result of experiment with esculin iron agar in the following experiment (4.conversion of Ginsenoside Rb1) to confirm ginsenoside conversion ability of SRCM102370. .
이에, 유산균주 중에서 내산성, 내담즙성 및 항균활성이 우수할 뿐만 아니라, 효소활성도 우수한 Lactobacillus plantarum SRCM 102370을 최종균주로 선발하였다.Thus,
4. 4. GinsenosideGinsenoside Rb1의Of Rb1 전환 transform
선발된 최종균주의 적합성을 판단하기 위해 하기와 같은 방법으로 Ginsenoside Rb1의 전환을 평가하였다.In order to determine the suitability of the selected final strain was evaluated the conversion of Ginsenoside Rb1 as follows.
MRS 액체배지에서 24시간동안 배양한 균주를 다시 2 mM의 ginsenoside Rb1을 0.2 um membrain filter로 여과하여 멸균한 후 실험에 사용하였다. Strains incubated for 24 hours in MRS liquid medium were again sterilized by filtering 2 mM ginsenoside Rb1 with a 0.2 um membrain filter.
NB 액체 배지에 ginsenoside Rb1의 최종 농도가 0.5 mM이 되도록 접종하고 37℃, 48시간 배양하여 반응액을 회수하였다. 반응액은 수포화 n-butanol로 사포닌 성분을 추출하여 분석하였다. The reaction solution was recovered by inoculating NB liquid medium to a final concentration of ginsenoside Rb1 of 0.5 mM and incubating for 48 hours at 37 ° C. The reaction solution was analyzed by extracting the saponin components with saturated n-butanol.
TLC는 butanol : Ethyl acetate : water (10 : 2 : 8, v/v/v) 용매로 전개한 후, 10% 황산용액을 분무하고 110℃에서 10분간 가열하여 발색시켰다.TLC was developed with butanol: Ethyl acetate: water (10: 2: 8, v / v / v) solvent, followed by spraying with 10% sulfuric acid solution and heating at 110 ° C. for 10 minutes.
그 결과는 도 4와 같다. The result is shown in FIG. 4.
도 4에 나와 있는 바와 같이, Ginsenoside Rb1이 0.5 mM와 유산균을 반응시킨 반응물을 n-butanol을 이용해 전개한 결과, Rg3와 compound K로 변환된 것으로 보이는 것은 SRCM 102370인 것을 확인할 수 있었다.As shown in FIG. 4, when the reaction product of Ginsenoside Rb1 reacted with 0.5 mM and lactic acid was developed using n-butanol, it was confirmed that
5. 5. 흑삼분말Black Ginseng Powder 용액에서 In solution 생존률Survival rate 검토 Review
선발된 최종균주의 발효 조성물 제조에 대한 적합성을 판단하기 위해 하기와 같은 방법으로 흑삼분말 용액에서의 생존률을 검토하였다.In order to determine the suitability for the production of the fermentation composition of the selected final strain was examined the survival rate in the black ginseng powder solution in the following manner.
흑삼분말 1%와 정제수만으로 분말 액체배지를 제조하고 균주는 106 CFU/mL을 접종하고 37℃, 24시간 진탕배양 후, 초기균수를 토대로 생존률을 검토하였다.Powdered liquid medium was prepared using only 1% of black ginseng powder and purified water, and the strain was inoculated with 10 6 CFU / mL, and the survival rate was examined based on the initial bacterial count after incubation at 37 ° C. for 24 hours.
발효 종료 시, pH와 총산을 함께 측정하여 균주의 발효를 검토하였다.At the end of fermentation, the pH and total acid were measured together to examine the fermentation of the strain.
그 결과는 하기 표 7과 같다.The results are shown in Table 7 below.
표 7을 보면 알 수 있듯이, 초기균수에 비해 SRCM 102226은 생육이 억제된 것으로 보이고, pH의 변화도 거의 무첨가군의 pH(4.96)와 비교할 때 거의 차이가 없는 것으로 보아 발효가 일어나지 않은 것으로 확인되었다. As can be seen from Table 7, the growth of
SRCM 102370은 흑삼에 발효를 진행한 경우 생균수가 약 100배 정도 증가한 Log 8.24 CFU/mL로 확인되었으며, 유산균 발효를 확인할 수 있는 pH의 변화도 확인되어 발효 적성이 좋은 것을 확인할 수 있었다.
이에 최종균주인 락토바실러스 플란타럼(Lactobacillus plantarum) SRCM 102370은 흑삼의 발효에 사용되는 유산균으로 적합하다고 판단된다.The final strain
[[ 실험예Experimental Example 4] 발효 최적 조건 확립 4] Establishment of Optimal Fermentation Conditions
흑삼 유산균 발효 조성물의 제조에서 발효의 최적 조건을 확립하기 위해, 흑삼분말 1%를 기준으로 0.5, 1, 2%의 흑삼 분말액을 기반으로 설탕으로 당의 농도를 5 brix로 맞추고 유산균 접종량(1%, 3%, 5%)을 달리하고 0, 24, 48시간 배양하여 ginsenoside가 변화되는 것을 TLC 상으로 확인하였으며, pH 변화, 총산도 변화 및 생균수 변화를 관찰하였다.In order to establish the optimum conditions of fermentation in the production of black ginseng lactobacillus fermentation composition, sugar concentration was adjusted to 5 brix based on 0.5, 1, and 2% black ginseng powder solution based on 1% black ginseng powder, and the amount of lactic acid bacteria inoculated (1% , 3%, 5%) was incubated for 0, 24, 48 hours and the ginsenoside changes were confirmed by TLC phase, pH change, total acidity change and viable cell count were observed.
pH 변화, 총산도 변화 및 생균수 변화의 결과는 도 5 내지 도 7와 같다.The results of pH change, total acidity change and viable cell number change are shown in FIGS. 5 to 7.
도 5는 발효시간에 따른 흑삼분말 농도별, 균주 접종농도별 pH 변화 그래프, 도 6은 발효시간에 따른 흑삼분말 농도별, 균주농도별 총산도 변화 그래프, 도 7은 발효시간에 따른 흑삼분말 농도별, 균주농도별 생균수 변화 그래프(Log CFU/mL)이다.5 is a graph of pH change by black ginseng powder concentration, strain inoculation concentration according to fermentation time, Figure 6 is a graph of change in total acidity by black ginseng powder concentration, strain concentration according to fermentation time, Figure 7 is black ginseng powder concentration according to fermentation time The number of viable cell number change by star, strain concentration (Log CFU / mL).
먼저, TLC 상의 결과를 토대로 ginsenoside 패턴 변화를 고려 할 때, major ginsenoside가 변화하는 것은 균주 접종량이 5%일 때 더 효과적인 것으로 사료된다.First, considering the change of ginsenoside pattern based on the TLC results, the change of major ginsenoside is more effective at 5% strain inoculation.
또한, 도 5 내지 도 7에 나타난 바와 같이, pH와 총산의 변화로 흑삼분말은 최소 1%이상에서 발효조건이 성립되고, 24시간보다는 48시간까지 발효하는 것이 이상적으로 확인되었다.In addition, as shown in Figures 5 to 7, the change in pH and total acid black ginseng powder is at least 1% fermentation conditions were established, it was confirmed that the fermentation to 48 hours rather than 24 hours.
또한, 생균수 확인 결과 균주 접종량은 최소 3%이상으로 접종하는 것이 생균수가 적합하다고 확인되었다.In addition, as a result of confirming the viable cell count, it was confirmed that the viable cell number was suitably inoculated at least 3% of the strain inoculation amount.
따라서, 이 실험 결과로 흑삼분말이 최소 1%이상의 농도의 흑삼분말액을 사용하고, 발효는 48시간이상 진행하되 균주(유산균) 접종량은 3% 이상으로 조건을 확립하였으며, 흑삼분말이 2%의 농도의 흑삼분말액을 사용하고, 발효는 48시간 진행하되 균주(유산균) 접종량은 5%로 최적조건을 확립하였다.Therefore, as a result of this experiment, black ginseng powder was used at least 1% of black ginseng powder, fermentation proceeded for more than 48 hours, but the strain (lactic acid bacteria) inoculation amount was set to 3% or more, and black ginseng powder was 2% The concentration of black ginseng powder was used, and fermentation proceeded for 48 hours, but the optimum amount of strain (lactic acid bacteria) inoculation was 5%.
[[ 실시예Example ] 흑삼 유산균 발효 조성물Black Ginseng Lactic Acid Bacteria Fermentation Composition
정제수에 흑삼분말액 100중량%를 기준으로, 흑삼분말 1중량%를 첨가하고 설탕으로 당의 농도를 5brix로 맞춰 제조된 흑삼분말액을 멸균하고 냉각시킨 후 유산균 5중량%를 접종하고 37℃에서 48시간동안 발효하여 제조하였다.Based on 100% by weight of black ginseng powder to purified water, add 1% by weight of black ginseng powder, sterilize and cool black ginseng powder prepared by adjusting sugar concentration to 5brix, inoculate 5% by weight of lactic acid bacteria, and inoculate 48% at 37 ℃. Prepared by fermentation over time.
[[ 실험예Experimental Example 5] 흑삼 유산균 발효 조성물의 평가 5] Evaluation of Black Ginseng Lactic Acid Bacteria Fermentation Composition
최종 확립된 조건으로 제조된 흑삼 유산균 발효 조성물인 실시예를 평가하기 위해 기능성 특성과 이화학적 특성을 하기와 같이 평가하였다.Functional properties and physicochemical properties were evaluated as follows in order to evaluate the embodiment of the black ginseng lactic acid bacteria fermentation composition prepared under the finally established conditions.
기능성 특성으로는 진세노사이드 함량, 유리아미노산 함량, 유기산 함량 및 항산화 활성을 평가하였다.Functional properties were evaluated for ginsenoside content, free amino acid content, organic acid content and antioxidant activity.
1. 진세노사이드 함량1. Ginsenoside content
실시예와 비교예의 진세노사이드 함량을 측정하여 비교 평가하였다.The ginsenoside content of the Example and the comparative example was measured and evaluated.
그 결과는 하기 표 8과 같으며, 하기 표 8에서 WG: 수삼(가공전), JK: 시판 흑삼으로 비교예이고, JA는 실시예이다. 단위는 mg/g이고, -는 Not detected이다.The results are shown in Table 8 below. In Table 8, WG: fresh ginseng (before processing) and JK: commercial black ginseng were comparative examples, and JA is an example. The unit is mg / g and-is Not detected.
상기 표 8을 보면 알 수 있듯이, JA(실시예)는 가공 전인 WG(수삼)에 비해 비해 Rg3, Rk1, Rg5 등의 함량이 증가됨을 확인할 수 있었고, JK와 달리 주요사포닌으로 알려진 Rg1과 Rb1이 진안 홍삼 연구소의 흑삼 제조기술에 의해 특이 진세노사이드(Rg3, Rk1, Rg5 등)로 전환 된 것으로 확인할 수 있었다. As can be seen from Table 8, JA (Example) was found to increase the content of Rg3, Rk1, Rg5, etc. compared to WG (sewage) before processing, unlike JK Rg1 and Rb1 known as major saponins It was confirmed that specific ginsenosides (Rg3, Rk1, Rg5, etc.) were converted by black ginseng manufacturing technology of Jinan Red Ginseng Research Institute.
2. 2. 유리아미노산Free amino acids 및 유기산 함량 And organic acid content
실시예를 유산균으로 발효시키지 않은 비교예(control)와 비교하기 위해, 유리아미노산과 유기산을 비교 평가하였다.In order to compare the Example with the control which was not fermented with lactic acid bacteria, free amino acid and organic acid were compared and evaluated.
유리아미노산은 시료 5 g을 취하여 0.2 N HCl로 50 mL까지 용량을 맞추고 37℃, 3시간 교반한 후, 0.2 ㎛ syringe filter에 통과시킨 후 시료로 사용하였다.5 g of the free amino acid was sampled, adjusted to 50 mL with 0.2 N HCl, stirred at 37 ° C. for 3 hours, and passed through a 0.2 μm syringe filter to use as a sample.
유리 아미노산 분석 조건은 하기 표 9과 같이 설정하여 진행하였다.Free amino acid analysis conditions were set as shown in Table 9 below.
유기산은 High Perfomrnace Liquid Chromatography (HPLC)를 이용하여 실시하였고, 시료 5g에 증류수로 50 mL로 맞추고 37℃, 3시간 교반한 후, 0.45㎛ membrane filter에 통과시킨 후 시료로 사용하였다. The organic acid was performed using High Perfomrnace Liquid Chromatography (HPLC). The sample was adjusted to 50 mL with distilled water at 5 g of sample, stirred at 37 ° C. for 3 hours, and passed through a 0.45 μm membrane filter.
유리산 분석 조건은 하기 표 10과 같이 설정하여 진행하였다.Free acid analysis conditions were set as shown in Table 10 below.
실시예 및 비교예의 유리아미노산 및 유기산의 함량을 비교한 결과는 하기 도 8 및 표 11와 같다.The results of comparing the contents of the free amino acid and the organic acid in Examples and Comparative Examples are as shown in FIG. 8 and Table 11.
도 8을 보면 알 수 있듯이, 비교예(control)와 실시예(treatment)의 아미노산 함량은 총 아미노산 함량으로 비교할 경우 약 3배 이상 증가한 것을 확인할 수 있어 발효 중 효소활성이 나타남을 예상할 수 있다. As can be seen from Figure 8, the amino acid content of the control (treatment) and the example (treatment) can be confirmed that the increase of about three times or more when compared to the total amino acid content can be expected to appear the enzyme activity during fermentation.
또한 흑삼 유산균 발효 조성물인 실시예는 특히 필수아미노산으로 분류되는 threonine, valine, methionine, isoleucine, leucine, phenylalanine, lysine, histidine이 모두 발효 전에 비해 증가하여, 성장기 어린이와 노약자의 건강증진에 도움이 될 것으로 사료된다.In addition, the example of black ginseng lactobacillus fermentation composition, especially threonine, valine, methionine, isoleucine, leucine, phenylalanine, lysine, and histidine, which are classified as essential amino acids, will be increased compared to before fermentation, which will help to improve the health of growing children and the elderly. It is feed.
본 연구결과는 실시예(흑삼 유산균 발효 조성물)의 유리아미노산 결과로써, 발효 후 산물은 carnosine > beta-alanine > Leusine > Valine > gamma-aminobutyric acid > Lysine > Arginine 순으로 아미노산이 분석되었고, 전체적으로 아미노산 함량이 증가하여 쓴맛, 단맛, 신맛, 감칠맛 등의 맛이 풍부해졌음을 의미한다.The results of this study are the results of free amino acids in Examples (Black Ginseng Lactic Acid Bacteria Fermentation Composition). This increases the richness of bitterness, sweetness, sourness, and umami.
또한, 상기 표 11를 보면 알 수 있듯이, 총 7종의 유기산을 분석한 결과 발효 전 비교예(control)과 비교하여 실시예(treatment)에서 그 값이 크게 증가한 유기산은 Lactic acid > Acetic acid > Succinic acid 순으로 분석되었고, 특히 3종의 유기산은 모두 발효식품에서 주로 검출되는 산으로 흑삼 유산균 발효 조성물의 특유의 산미와 풍미에 영향을 준 것으로 사료된다.In addition, as can be seen from Table 11, as a result of analyzing a total of seven organic acids, the organic acid of which the value was greatly increased in Example compared to the control (treatment) before fermentation was Lactic acid> Acetic acid> Succinic In the order of acid, all three types of organic acids were found mainly in fermented foods, which may affect the unique acidity and flavor of black ginseng lactobacillus fermentation composition.
3. 항산화 활성3. Antioxidant Activity
실시예를 유산균으로 발효시키지 않은 비교예(control)와 비교하기 위해, 항산화 활성을 비교 평가하였다.In order to compare the Example with the control which was not fermented with lactic acid bacteria, antioxidant activity was compared and evaluated.
그 결과는 하기 표 12와 같다.The results are shown in Table 12 below.
상기 표 12를 보면 알 수 있듯이, 발효 전인 비교예(control)의 DPPH free radical 제거 활성은 시료의 처리농도에 따라 점차 증가하여 10000 ㎍/mL의 농도에서 40.66±2.46%로 항산화 효과를 보였고, 발효 후인 실시예(treatment)의 DPPH free radical 제거 활성은 각 시료의 처리농도에 따라 점차 증가하여 10000 ㎍/mL의 농도에서 45.58±1.41%로 항산화 효과를 보이는 것을 확인할 수 있었다.As can be seen from Table 12, DPPH free radical removal activity of the control before the fermentation (control) gradually increased with the treatment concentration of the sample showed an antioxidant effect of 40.66 ± 2.46% at a concentration of 10000 ㎍ / mL, fermentation The DPPH free radical removal activity of the latter example (treatment) was gradually increased with the treatment concentration of each sample was confirmed that the antioxidant effect was shown to 45.58 ± 1.41% at a concentration of 10000 ㎍ / mL.
실시예 및 비교예 모두 농도가 높아질수록 항산화 활성이 높아졌으나, 실시예가 비교예보다 높은 항산화 효과를 보이는 것을 확인하였다.In both Examples and Comparative Examples, the higher the concentration, the higher the antioxidant activity, but the Example showed a higher antioxidant effect than the Comparative Example.
4. 면역 활성 평가4. Assessment of immune activity
실시예를 유산균으로 발효시키지 않은 비교예(control)의 면역 활성을 평가하기 위해, 비장 세포에 대한 독성을 평가하였다.In order to evaluate the immune activity of the control in which the example was not fermented with lactic acid bacteria, toxicity against spleen cells was evaluated.
즉, 기존의 면역력 증진에 도움이 된다고 알려진 흑삼에 유산균을 발효시킬 경우 어떤 변화를 나타내는지 확인하고자 진행하였고, 먼저 시료별 처리에 따른 비장세포의 독성 농도를 확인하기 위하여, 비장세포에 실시예 및 비교예를 각각 농도별로 처리하여 24시간 이후에 비장세포의 생존율을 측정하는 것으로 세포 생존율 분석을 수행하였다.That is, to proceed with the fermentation of lactic acid bacteria to black ginseng known to help to improve the existing immunity proceeds to determine what changes, first to check the toxic concentration of the splenocytes according to the treatment by sample, Example and The cell viability analysis was performed by measuring the viability of splenocytes after 24 hours by treating the comparative examples for each concentration.
그 결과는 도 9와 같다.The result is shown in FIG.
도 9에 나타난 바와 같이, 처리 24시간 후 발효 전 산물인 비교예(control)의 경우 1㎍/mL~500㎍/mL의 농도에서는 세포 독성을 보이지 않았으나, 1000 ㎍/mL에서 시료 자체의 독성으로 인해 세포 생존율을 감소시킨 것으로 관찰되었고, 발효 후 산물인 실시예(treatment)의 경우 1㎍/mL~1000㎍/mL의 농도에서도 세포 독성이 없는 것으로 나타났다. As shown in FIG. 9, the control product, which is a product before fermentation after 24 hours, did not show cytotoxicity at a concentration of 1 μg / mL to 500 μg / mL, but at 1000 μg / mL as the toxicity of the sample itself. As a result, it was observed that cell viability was reduced, and in the case of the product after fermentation, the treatment was not cytotoxic even at a concentration of 1 μg / mL to 1000 μg / mL.
이러한 결과를 토대로 기존의 흑삼은 그 자체를 섭취할 경우 섭취하는 양과 농도가 높아질수록 독성이 나타날 수 있고, 이를 실시예와 같이 유산균 발효하게 되면 동일한 농도에서도 세포 독성이 나타나지 않음으로써 보다 안전하다고 사료된다.Based on these results, the existing black ginseng may be toxic as the amount and concentration of the ingested food itself increases, and when it is fermented as in Example, it is considered safer because it does not show cytotoxicity at the same concentration. .
또한, 실시예와 비교예의 비교 분석을 위해 세포 증식율에 미치는 영향을 확인하기 위하여, 실시예와 비교예가 세포에 독성을 미치지 않는 500 ㎍/mL의 농도를 공시료의 최고 농도로 설정하고 Cy(cyclophosphamide)를 처리하여 24시간 이후에 세포 증식율을 측정하였다.In addition, in order to confirm the effect on the cell proliferation rate for the comparative analysis of the Examples and Comparative Examples, the concentration of 500 ㎍ / mL in which the Examples and Comparative Examples are not toxic to the cells was set to the highest concentration of the test sample and Cy (cyclophosphamide) ) And cell proliferation was measured after 24 hours.
그 결과는 도 10과 같다.The result is shown in FIG.
도 10에 나타난 바와 같이, 비교예와 비교하여 Cy를 처리한 실시예의 대식세포 증식능은 약 54~60%로 확인할 수 있었다.As shown in FIG. 10, the macrophage proliferation ability of the Example treated with Cy compared to the comparative example was about 54-60%.
즉, 비교예는 300 ㎍/mL의 농도에서 경우 24시간 경과 시 79.2±4.3%로 나타났으나, 실시예는 100 ㎍/mL의 농도에서 경우 24시간 경과 시 88.7 ±3.2%로 나타나는 것을 확인할 수 있었다.That is, the comparative example was found to be 79.2 ± 4.3% after 24 hours at the concentration of 300 ㎍ / mL, but the example was found to appear 88.7 ± 3.2% after 24 hours at the concentration of 100 ㎍ / mL there was.
다시 말해, 유산균 발효를 진행한 실시예는 보다 낮은 농도, 또는 미량 섭취만으로도 발효 전의 흑삼인 비교예보다 면역 증진에 영향을 미칠 수 있음으로 판단될 수 있다.In other words, the embodiment in which the lactic acid bacterium fermentation is performed may be judged that lower concentration, or even a small amount of intake, may affect immunity enhancement than the comparative example of black ginseng before fermentation.
또한, 실시예 및 비교예 각각의 자연살해세포(Natural killer cell, NK cell)의 활성에 미치는 영향을 알아보기 위해, 24시간 후 시료 농도에 따른 YAC-1 세포 생존율을 분석하였다. In addition, to determine the effect on the activity of natural killer cells (Natural killer cells, NK cells) of each of the Examples and Comparative Examples, YAC-1 cell viability according to the sample concentration after 24 hours was analyzed.
그 결과는 도 11과 같다.The result is shown in FIG.
도 9에 나타난 바와 같이, 대조군과 비교하여 비교예와 실시예는 각각 500㎍/m의 농도에서는 유의적인 차이가 없었으나, 1000㎍/mL 이상의 농도에서 세포 생존율이 유의하게 감소된 것으로 나타났다. As shown in FIG. 9, the comparative examples and the examples were not significantly different in the concentration of 500 µg / m, respectively, compared to the control group, but the cell viability was significantly decreased at the concentration of 1000 µg / mL or more.
따라서 각 시료의 농도에 따른 NK cell 활성 비교 분석을 위해 500㎍/mL을 시료의 최대 처리 농도로 설정하여 시험을 진행하였다.Therefore, for the comparative analysis of NK cell activity according to the concentration of each sample, 500 μg / mL was set as the maximum treatment concentration of the sample.
NK 세포는 선천성 면역 반응 중 하나로 바이러스에 감염된 세포, 종양 세포, 비정상 세포, 표적 세포를 인지하여 결합한 뒤 독성과립들을 세포에 통과시켜 세포사멸을 유도한다. NK 세포의 활성은 다양한 활성화 및 억제 수용체를 통한 신호전달 균형에 의해 조절되는데, 이렇게 세포와 결합했을 때 오는 활성 신호와 억제 신호를 인식하여 정상 세포는 공격하지 않고 비정상 세포는 제거함으로써 세포 살해 활성이 조절된다. NK cells are one of the innate immune responses that recognize and bind to virus-infected cells, tumor cells, abnormal cells, and target cells, and then pass toxic granules through the cells to induce apoptosis. The activity of NK cells is regulated by the balance of signal transduction through various activation and suppression receptors. By recognizing the activation and suppression signals that come with these cells, normal cells are not attacked and abnormal cells are eliminated to remove cell killing activity. Adjusted.
NK 세포의 활성 측정은 YAC-1 세포에 대한 NK 세포의 공격으로 인해 발생하는 LDH를 측정함으로써 평가하였다.Determination of NK cell activity was assessed by measuring LDH resulting from the attack of NK cells on YAC-1 cells.
그 결과는 표 13 및 도 12와 같다. The results are shown in Table 13 and FIG.
표 13 및 도 12에 나타난 바와 같이, 실시예 및 비교예는 농도가 증가함에 따라 NK의 활성이 점차 증가된 것으로 나타났는데, 비교예의 경우 10 ㎍/mL에서 106.5±1.8%, 30 ㎍/mL에서 128.4±4.0%, 50 ㎍/mL에서 134.7±3.8%, 100 ㎍/mL에서 142.7±1.8%, 300 ㎍/mL에서 160.4±5.1, 500 ㎍/mL에서 158.5±3.7로 조사되었으며, 실시예의 경우 10 ㎍/mL에서 114.9±2.2%, 30 ㎍/mL에서 135.0±2.8%, 50 ㎍/mL에서 145.7±4.8%, 100 ㎍/mL에서 151.1±4.7%, 300 ㎍/mL에서 173.6±6.8, 500㎍/mL에서 162.9±5.0로 나타나 실시예는 비교예에 비해 NK 세포 활성이 더 높은 것으로 확인되었다.As shown in Table 13 and Figure 12, Examples and Comparative Examples showed that the activity of NK gradually increased as the concentration was increased, in the case of Comparative Example at 106.5 ± 1.8%, 30 ㎍ / mL at 10 ㎍ / mL 128.4 ± 4.0%, 134.7 ± 3.8% at 50 μg / mL, 142.7 ± 1.8% at 100 μg / mL, 160.4 ± 5.1 at 300 μg / mL, and 158.5 ± 3.7 at 500 μg / mL. 114.9 ± 2.2% at μg / mL, 135.0 ± 2.8% at 30 μg / mL, 145.7 ± 4.8% at 50 μg / mL, 151.1 ± 4.7% at 100 μg / mL, 173.6 ± 6.8 at 500 μg / mL, 500 μg 162.9 ± 5.0 at / mL showed that the NK cell activity is higher than the comparative example.
5. 이화학적 특성5. Physicochemical Properties
실시예를 유산균으로 발효시키지 않은 비교예(control)와 비교하기 위해, 이화학적 특성을 비교 평가하였다.In order to compare the example with a control that was not fermented with lactic acid bacteria, physicochemical characteristics were evaluated.
그 결과는 하기 표 14와 같다. The results are shown in Table 14 below.
상기 표 14를 보면 알 수 있듯이, 실시예(Treatment)는 발효가 안정적으로 진행되어 초기 균 접종량에 비해 발효 종료 시 생균수는 Log 8.57 CFU/mL로 관찰되었고 산이 증가함에 따라 비교예(control)보다 pH가 낮아져 pH도 3.54로 나타나는 것을 확인할 수 있었다.As can be seen from Table 14, in the Example (Treatment), the fermentation proceeded stably and the viable cell count at the end of fermentation was observed at Log 8.57 CFU / mL compared to the initial inoculation amount, and as the acid was increased, It was confirmed that the pH was lowered and the pH was also expressed as 3.54.
Claims (8)
흑삼분말액에 기탁번호 KFCC11812P인 Lactobacillus plantarum SRCM 102370을 접종하여 흑삼 분말액을 발효시킨 후 발효된 흑삼 분말액을 살균 및 냉각시켜 흑삼 유산균 발효액을 제조하는 발효액 준비단계;
부재료를 계량하여 준비하는 부재료 준비단계;
상기 흑삼 유산균 발효액과 부재료를 혼합하여 혼합물을 제조하는 혼합단계;
상기 혼합물을 교반하는 교반단계;
상기 교반된 혼합물을 포장용기에 충진한 후 살균시키는 충진단계 및
상기 살균된 혼합물을 냉각시켜 흑삼발효젤리를 제조하는 혼합물 냉각단계를 포함하는 흑삼발효젤리 제조방법.
In the black ginseng fermented jelly manufacturing method,
Fermentation broth preparation step of inoculating Lactobacillus plantarum SRCM 102370 with accession number KFCC11812P to black ginseng powder solution to ferment black ginseng powder solution, and then sterilizing and cooling the fermented black ginseng powder solution to produce black ginseng lactic acid fermentation broth;
A subsidiary material preparation step of measuring and preparing the subsidiary material;
A mixing step of preparing a mixture by mixing the black ginseng lactic acid bacteria fermentation broth and an ingredient;
A stirring step of stirring the mixture;
A filling step of sterilizing and then filling the stirred mixture in a packaging container;
Black ginseng fermentation jelly manufacturing method comprising the step of cooling the sterilized mixture to produce a black ginseng fermentation jelly.
상기 부재료는,
감미제, 효소스테비아, 수크랄로스, 식이섬유, 곤약가루, 잔탄검, 로커스콩검, 카라기난, 구연산, 구연산삼나트륨 및 비타민 C를 포함하는 흑삼발효젤리 제조방법.
The method of claim 1,
The submaterial is
Method for producing black ginseng fermented jelly comprising sweetener, enzyme stevia, sucralose, dietary fiber, konjac powder, xanthan gum, locus bean gum, carrageenan, citric acid, trisodium citrate and vitamin C.
상기 감미제는,
에리스리톨 및 락츄로스 중 하나인 것을 특징으로 하는 흑삼발효젤리 제조방법.
The method of claim 2,
The sweetener,
Method for producing black ginseng fermented jelly, characterized in that it is one of erythritol and lacchurose.
상기 부재료는,
홍삼농축액 및 식품첨가제를 더 포함하고,
상기 식품첨가제는,
정제수 및 농축액 중 하나 이상을 포함하는 것을 특징으로 하는 흑삼발효젤리 제조방법.
The method of claim 2,
The submaterial is
Further comprising red ginseng concentrate and food additives,
The food additive,
Black ginseng fermented jelly manufacturing method comprising at least one of purified water and concentrate.
상기 부재료는,
요구르트향 분말을 더 포함하는 것을 특징으로 하는 흑삼발효젤리 제조방법.
The method of claim 4, wherein
The submaterial is
Black ginseng fermented jelly manufacturing method comprising the yogurt flavor powder further.
흑삼발효젤리 제조방법은,
상기 교반단계 이후, 상기 교반된 혼합물에 착향료를 첨가하는 착향료 첨가단계를 더 포함하는 흑삼발효젤리 제조방법.
The method of claim 1,
Black ginseng fermented jelly manufacturing method,
After the stirring step, black ginseng fermentation jelly manufacturing method further comprises a flavoring step of adding a flavoring agent to the stirred mixture.
상기 부재료는,
키위 및 파파야를 더 포함하는 흑삼발효젤리 제조방법.
The method of claim 2,
The submaterial is
Black ginseng fermented jelly manufacturing method further comprising kiwi and papaya.
Black ginseng fermented jelly, which is prepared by the method of any one of claims 1 to 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190015048A KR102015783B1 (en) | 2019-02-08 | 2019-02-08 | Black ginseng fermented jelly and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190015048A KR102015783B1 (en) | 2019-02-08 | 2019-02-08 | Black ginseng fermented jelly and its manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102015783B1 true KR102015783B1 (en) | 2019-10-23 |
Family
ID=68461061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190015048A KR102015783B1 (en) | 2019-02-08 | 2019-02-08 | Black ginseng fermented jelly and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102015783B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210081126A (en) | 2019-12-23 | 2021-07-01 | 전주대학교 산학협력단 | manufacturing method of jelly black ginseng fermented |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101324282B1 (en) * | 2012-06-25 | 2013-11-01 | 서범구 | Preparation method of fermented red ginseng for improving immunity of the human body using effective micro-organisms |
KR20170000021A (en) * | 2015-06-22 | 2017-01-02 | (주)고철남홍삼 | Red ginsang jelly and Method for manufacturing thereof |
KR20170061959A (en) * | 2015-11-27 | 2017-06-07 | 농업회사법인주식회사 한국흑홍삼 | Preparation method of fermented ginseng and fermented black-red ginseng with active ginsenoside heightening rate absorption |
KR20170103722A (en) | 2017-08-24 | 2017-09-13 | 농업회사법인 금산흑삼주식회사 | Manufacturing method of Black ginseng coffee |
-
2019
- 2019-02-08 KR KR1020190015048A patent/KR102015783B1/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101324282B1 (en) * | 2012-06-25 | 2013-11-01 | 서범구 | Preparation method of fermented red ginseng for improving immunity of the human body using effective micro-organisms |
KR20170000021A (en) * | 2015-06-22 | 2017-01-02 | (주)고철남홍삼 | Red ginsang jelly and Method for manufacturing thereof |
KR20170061959A (en) * | 2015-11-27 | 2017-06-07 | 농업회사법인주식회사 한국흑홍삼 | Preparation method of fermented ginseng and fermented black-red ginseng with active ginsenoside heightening rate absorption |
KR20170103722A (en) | 2017-08-24 | 2017-09-13 | 농업회사법인 금산흑삼주식회사 | Manufacturing method of Black ginseng coffee |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210081126A (en) | 2019-12-23 | 2021-07-01 | 전주대학교 산학협력단 | manufacturing method of jelly black ginseng fermented |
KR102370096B1 (en) * | 2019-12-23 | 2022-03-04 | 전주대학교 산학협력단 | manufacturing method of jelly black ginseng fermented |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101274664B1 (en) | Beverage composition containing mulberry leaves extract and ferment | |
KR102431335B1 (en) | Novel starter of Lactobacillus fermentum EFEL6800 with probiotic activity | |
TWI520685B (en) | Lactic acid bacteria proliferation promoter | |
JP5011543B2 (en) | Method for producing fermented material containing GABA | |
JP6955808B1 (en) | How to make fermented honey | |
JP4119656B2 (en) | Antioxidant | |
KR20040094489A (en) | PRODUCTION METHOD OF γ-AMINOBUTYRIC ACID-ENFORCED FERMENTATIVE PRODUCTS BY LACTIC ACID BACTERIA, γ-AMINOBUTYRIC ACID-ENFORCED FERMENTATIVE PRODUCTS PRODUCTED BY THE METHOD AND THEIR UTILIZATION | |
KR102015783B1 (en) | Black ginseng fermented jelly and its manufacturing method | |
KR102387269B1 (en) | Composition and method for yogurt with enhanced GABA using barley and yogurt produced by the same | |
CN111117926B (en) | Strain for high yield of gamma-aminobutyric acid and application of strain to preparation of gamma-aminobutyric acid-rich fruit juice | |
KR101746826B1 (en) | Method for Preparing Soy Sikhye Yogurt and the Soy Sikhye Yogurt Prepared by the Same Method | |
KR100661824B1 (en) | -1 Lactobacillus brevis OPY-1 and fermented milk containing thereof | |
KR101828494B1 (en) | Manufacturing method for fermented beverage using lactic acid bacterias | |
JP2020061977A (en) | Novel lactic acid bacterium that belongs to streptococcus salivarius, and use of the same | |
KR102053735B1 (en) | Black ginseng lactic acid bacteria fermentation composition and method for producing the same | |
JP6921350B1 (en) | New lactic acid bacteria belonging to Lactobacillus plantarum isolated from Yaezakura flowers and their utilization | |
JP2015073483A (en) | Lactic acid bacteria which has adhesiveness to alimentary canal mucosa | |
KR102055053B1 (en) | Starter containing of lactic acid bacteria with superior effect for alcohol degradation activity and cheese containing alcohol metabolism using the same | |
JP6635479B1 (en) | A novel lactic acid bacterium belonging to Enterococcus faecium and its use | |
KR20220011937A (en) | Lactobacillus paracasei GFC_GFV5 for removing hangover and food composition comprising the same as an effective ingredient | |
KR101804778B1 (en) | Lactobacillus plantarum HY7716 having production capability of the rare sugar allulose, and Products containing thereof as effective component | |
Anthony et al. | Evaluation of Mucuna beans flour fermented with Lactobacillus plantarum as a probiotic food | |
KR102567791B1 (en) | Lactobacillus plantarum GFC_B001 for removing hangover and food composition comprising the same as an effective ingredient | |
KR100965961B1 (en) | Method for preparing ephedra sinica fermented by lactic acid bacteria | |
JP7444368B1 (en) | New lactic acid bacteria belonging to Lactiplantibacillus plantarum isolated from tulip flowers and their use |